rev-20191231
false2019FY000088792153,069,832falsetruefalseNew YorkNew York10004false2019FY0000890547--12-31falsetruefalseNoNoNew Yorkfalse20190000887921--12-3153,069,832falsetrueNoNo2002030550315353152101373333200008879212019-01-012019-12-310000887921rev:RevlonConsumerProductsCorporationMember2019-01-012019-12-31iso4217:USD00008879212019-06-28xbrli:shares00008879212019-12-310000887921rev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:TwoThousandNineteenSeniorUnsecuredLineofCreditAgreementMember2019-08-3100008879212018-12-31iso4217:USDxbrli:shares00008879212018-01-012018-12-310000887921rev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921us-gaap:CommonStockMember2018-12-310000887921us-gaap:AdditionalPaidInCapitalMember2018-12-310000887921us-gaap:TreasuryStockMember2018-12-310000887921us-gaap:RetainedEarningsMember2018-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310000887921us-gaap:TreasuryStockMember2019-10-012019-12-3100008879212019-10-012019-12-310000887921us-gaap:AdditionalPaidInCapitalMember2019-10-012019-12-310000887921us-gaap:RetainedEarningsMember2019-10-012019-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-10-012019-12-310000887921us-gaap:CommonStockMember2019-12-310000887921us-gaap:AdditionalPaidInCapitalMember2019-12-310000887921us-gaap:TreasuryStockMember2019-12-310000887921us-gaap:RetainedEarningsMember2019-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000887921us-gaap:CommonStockMember2017-12-310000887921us-gaap:AdditionalPaidInCapitalMember2017-12-310000887921us-gaap:TreasuryStockMember2017-12-310000887921us-gaap:RetainedEarningsMember2017-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMember2017-12-3100008879212017-12-310000887921us-gaap:AdditionalPaidInCapitalMember2018-01-012018-12-310000887921us-gaap:TreasuryStockMember2018-01-012018-12-310000887921us-gaap:RetainedEarningsMember2018-01-012018-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-01-012018-12-310000887921us-gaap:TreasuryStockMember2019-01-012019-12-310000887921us-gaap:TreasuryStockMemberus-gaap:CommonClassAMemberrev:RestrictedStockandRestrictedStockUnitsMember2019-01-012019-12-310000887921us-gaap:TreasuryStockMemberus-gaap:CommonClassAMemberrev:RestrictedStockandRestrictedStockUnitsMember2018-01-012018-12-310000887921us-gaap:TreasuryStockMemberrev:RestrictedStockandRestrictedStockUnitsMember2018-01-012018-12-310000887921rev:TwoThousandNineteenTermLoanFacilityMember2019-01-012019-12-310000887921rev:TwoThousandNineteenTermLoanFacilityMember2018-01-012018-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndEighteenMember2019-01-012019-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndEighteenMember2018-01-012018-12-310000887921rev:RevlonConsumerProductsCorporationMember2018-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:PreferredStockMember2018-12-310000887921us-gaap:AdditionalPaidInCapitalMemberrev:RevlonConsumerProductsCorporationMember2018-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:RetainedEarningsMember2018-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMemberrev:RevlonConsumerProductsCorporationMember2018-12-310000887921us-gaap:AdditionalPaidInCapitalMemberrev:RevlonConsumerProductsCorporationMember2019-10-012019-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:RetainedEarningsMember2019-10-012019-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMemberrev:RevlonConsumerProductsCorporationMember2019-10-012019-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:PreferredStockMember2019-12-310000887921us-gaap:AdditionalPaidInCapitalMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:RetainedEarningsMember2019-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:PreferredStockMember2017-12-310000887921us-gaap:AdditionalPaidInCapitalMemberrev:RevlonConsumerProductsCorporationMember2017-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:RetainedEarningsMember2017-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMemberrev:RevlonConsumerProductsCorporationMember2017-12-310000887921rev:RevlonConsumerProductsCorporationMember2017-12-310000887921us-gaap:AdditionalPaidInCapitalMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:RetainedEarningsMember2018-01-012018-12-310000887921us-gaap:AccumulatedOtherComprehensiveIncomeMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921rev:TwoThousandNineteenTermLoanFacilityMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:TwoThousandNineteenTermLoanFacilityMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndEighteenMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndEighteenMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-31rev:segmentxbrli:pure0000887921us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberrev:ThreeLargestCustomersMember2019-01-012019-12-310000887921us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberrev:ThreeLargestCustomersMember2018-01-012018-12-310000887921rev:WallDisplayMember2019-12-310000887921rev:WallDisplayMember2018-12-310000887921rev:WallDisplayMember2019-01-012019-12-310000887921rev:WallDisplayMember2018-01-012018-12-310000887921rev:MassPortfolioMember2018-12-310000887921us-gaap:ForeignExchangeContractMember2019-12-310000887921srt:MinimumMemberus-gaap:LandImprovementsMember2019-01-012019-12-310000887921srt:MaximumMemberus-gaap:LandImprovementsMember2019-01-012019-12-310000887921us-gaap:BuildingAndBuildingImprovementsMembersrt:MinimumMember2019-01-012019-12-310000887921srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2019-01-012019-12-310000887921srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2019-01-012019-12-310000887921srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2019-01-012019-12-310000887921srt:MinimumMemberrev:CountersandTradeFixturesMember2019-01-012019-12-310000887921srt:MaximumMemberrev:CountersandTradeFixturesMember2019-01-012019-12-310000887921us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2019-01-012019-12-310000887921srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2019-01-012019-12-310000887921us-gaap:ComputerSoftwareIntangibleAssetMembersrt:MinimumMember2019-01-012019-12-310000887921us-gaap:ComputerSoftwareIntangibleAssetMembersrt:MaximumMember2019-01-012019-12-310000887921srt:MinimumMemberrev:WallDisplayMember2019-01-012019-12-310000887921srt:MaximumMemberrev:WallDisplayMember2019-01-012019-12-310000887921rev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921rev:TwoThousandEighteenOptimizationProgramMember2018-11-012019-12-310000887921us-gaap:EmployeeSeveranceMemberrev:TwoThousandEighteenOptimizationProgramMember2018-12-310000887921rev:TwoThousandEighteenOptimizationProgramMemberus-gaap:OtherRestructuringMember2018-12-310000887921us-gaap:RestructuringChargesMemberrev:TwoThousandEighteenOptimizationProgramMember2018-12-310000887921rev:RestructuringInventoryAdjustmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2018-12-310000887921rev:OtherRelatedChargesWithinSGAMemberrev:TwoThousandEighteenOptimizationProgramMember2018-12-310000887921rev:TwoThousandEighteenOptimizationProgramMember2018-12-310000887921us-gaap:EmployeeSeveranceMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921rev:TwoThousandEighteenOptimizationProgramMemberrev:RestructuringOtherRelatedChargesMember2019-01-012019-12-310000887921us-gaap:RestructuringChargesMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921rev:RestructuringInventoryAdjustmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921rev:OtherRelatedChargesWithinSGAMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921rev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921us-gaap:EmployeeSeveranceMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921rev:TwoThousandEighteenOptimizationProgramMemberus-gaap:OtherRestructuringMember2019-12-310000887921us-gaap:RestructuringChargesMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921rev:RestructuringInventoryAdjustmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921rev:OtherRelatedChargesWithinSGAMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921us-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMemberrev:PortfolioSegmentMember2019-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921us-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:TwoThousandEighteenOptimizationProgramMember2019-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921us-gaap:EmployeeSeveranceMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921us-gaap:ContractTerminationMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMemberus-gaap:OtherRestructuringMember2019-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMember2016-12-012019-12-310000887921us-gaap:EmployeeSeveranceMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2018-12-310000887921us-gaap:ContractTerminationMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2018-12-310000887921us-gaap:RestructuringChargesMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2018-12-310000887921rev:RestructuringInventoryAdjustmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2018-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMemberrev:RestructuringOtherRelatedChargesMember2018-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMember2018-12-310000887921us-gaap:EmployeeSeveranceMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921us-gaap:ContractTerminationMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921us-gaap:RestructuringChargesMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921rev:RestructuringInventoryAdjustmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMemberrev:RestructuringOtherRelatedChargesMember2019-01-012019-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921us-gaap:RestructuringChargesMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921rev:RestructuringInventoryAdjustmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMemberrev:RestructuringOtherRelatedChargesMember2019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921us-gaap:OperatingSegmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMemberrev:PortfolioSegmentMember2019-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921us-gaap:OperatingSegmentsMemberus-gaap:RestructuringChargesMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberus-gaap:RestructuringChargesMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2019-12-310000887921rev:TwoThousandEighteenOptimizationProgramMemberrev:RestructuringOtherRelatedChargesMember2018-12-310000887921rev:TwoThousandEighteenOptimizationProgramMemberrev:RestructuringOtherRelatedChargesMember2019-12-310000887921rev:OtherRestructuringPlansMemberus-gaap:EmployeeSeveranceMember2018-12-310000887921rev:OtherRestructuringPlansMemberus-gaap:EmployeeSeveranceMember2019-01-012019-12-310000887921rev:OtherRestructuringPlansMemberus-gaap:EmployeeSeveranceMember2019-12-310000887921rev:OtherRestructuringPlansMemberrev:RestructuringOtherRelatedChargesMember2018-12-310000887921rev:OtherRestructuringPlansMemberrev:RestructuringOtherRelatedChargesMember2019-01-012019-12-310000887921rev:OtherRestructuringPlansMemberrev:RestructuringOtherRelatedChargesMember2019-12-310000887921rev:OtherRestructuringPlansMember2018-12-310000887921rev:OtherRestructuringPlansMember2019-01-012019-12-310000887921rev:OtherRestructuringPlansMember2019-12-310000887921us-gaap:EmployeeSeveranceMemberrev:TwoThousandEighteenOptimizationProgramMember2017-12-310000887921us-gaap:EmployeeSeveranceMemberrev:TwoThousandEighteenOptimizationProgramMember2018-01-012018-12-310000887921rev:TwoThousandEighteenOptimizationProgramMemberrev:RestructuringOtherRelatedChargesMember2017-12-310000887921rev:TwoThousandEighteenOptimizationProgramMemberrev:RestructuringOtherRelatedChargesMember2018-01-012018-12-310000887921rev:TwoThousandEighteenOptimizationProgramMember2017-12-310000887921rev:TwoThousandEighteenOptimizationProgramMember2018-01-012018-12-310000887921us-gaap:EmployeeSeveranceMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2017-12-310000887921us-gaap:EmployeeSeveranceMemberrev:ElizabethArdenIntegrationRestructuringActionsMember2018-01-012018-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMemberrev:RestructuringOtherRelatedChargesMember2017-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMemberrev:RestructuringOtherRelatedChargesMember2018-01-012018-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMember2017-12-310000887921rev:ElizabethArdenIntegrationRestructuringActionsMember2018-01-012018-12-310000887921rev:OtherRestructuringPlansMemberus-gaap:EmployeeSeveranceMember2017-12-310000887921rev:OtherRestructuringPlansMemberus-gaap:EmployeeSeveranceMember2018-01-012018-12-310000887921rev:OtherRestructuringPlansMemberrev:RestructuringOtherRelatedChargesMember2017-12-310000887921rev:OtherRestructuringPlansMemberrev:RestructuringOtherRelatedChargesMember2018-01-012018-12-310000887921rev:OtherRestructuringPlansMemberrev:InventoryAdjustmentsandOtherRestructuringMember2017-12-310000887921rev:OtherRestructuringPlansMemberrev:InventoryAdjustmentsandOtherRestructuringMember2018-01-012018-12-310000887921rev:OtherRestructuringPlansMemberrev:InventoryAdjustmentsandOtherRestructuringMember2018-12-31rev:job_position0000887921rev:December2013ProgramMember2014-01-012014-12-310000887921rev:OperationsinChinaMemberus-gaap:SegmentDiscontinuedOperationsMember2019-01-012019-12-310000887921rev:OperationsinChinaMemberus-gaap:SegmentDiscontinuedOperationsMember2018-01-012018-12-310000887921rev:OperationsinChinaMemberus-gaap:SegmentDiscontinuedOperationsMember2019-12-310000887921rev:OperationsinChinaMemberus-gaap:SegmentDiscontinuedOperationsMember2018-12-310000887921us-gaap:LandAndLandImprovementsMember2019-12-310000887921us-gaap:LandAndLandImprovementsMember2018-12-310000887921us-gaap:BuildingAndBuildingImprovementsMember2019-12-310000887921us-gaap:BuildingAndBuildingImprovementsMember2018-12-310000887921us-gaap:MachineryAndEquipmentMember2019-12-310000887921us-gaap:MachineryAndEquipmentMember2018-12-310000887921us-gaap:FurnitureAndFixturesMember2019-12-310000887921us-gaap:FurnitureAndFixturesMember2018-12-310000887921rev:CountersandTradeFixturesMember2019-12-310000887921rev:CountersandTradeFixturesMember2018-12-310000887921us-gaap:LeaseholdImprovementsMember2019-12-310000887921us-gaap:LeaseholdImprovementsMember2018-12-310000887921us-gaap:ConstructionInProgressMember2019-12-310000887921us-gaap:ConstructionInProgressMember2018-12-310000887921rev:OperatingAndFinanceLeasesMember2019-12-310000887921rev:OperatingAndFinanceLeasesMember2018-12-310000887921rev:FinanceLeasesIncludedInMachineryAndEquipmentMember2018-12-310000887921us-gaap:AccountingStandardsUpdate201602Member2019-01-0100008879212017-01-012017-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMember2017-12-310000887921us-gaap:OperatingSegmentsMemberrev:PortfolioSegmentMember2017-12-310000887921rev:ElizabethArdenMemberus-gaap:OperatingSegmentsMember2017-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMember2017-12-310000887921rev:RevlonPortfolioElizabethArdenandFragrancesSegmentsMemberus-gaap:OperatingSegmentsMember2017-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMember2018-01-012018-12-310000887921us-gaap:OperatingSegmentsMemberrev:PortfolioSegmentMember2018-01-012018-12-310000887921rev:ElizabethArdenMemberus-gaap:OperatingSegmentsMember2018-01-012018-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMember2018-01-012018-12-310000887921rev:RevlonPortfolioElizabethArdenandFragrancesSegmentsMemberus-gaap:OperatingSegmentsMember2018-01-012018-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMember2018-12-310000887921us-gaap:OperatingSegmentsMemberrev:PortfolioSegmentMember2018-12-310000887921rev:ElizabethArdenMemberus-gaap:OperatingSegmentsMember2018-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMember2018-12-310000887921rev:RevlonPortfolioElizabethArdenandFragrancesSegmentsMemberus-gaap:OperatingSegmentsMember2018-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921rev:ElizabethArdenMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310000887921rev:RevlonPortfolioElizabethArdenandFragrancesSegmentsMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonSegmentMember2019-12-310000887921us-gaap:OperatingSegmentsMemberrev:PortfolioSegmentMember2019-12-310000887921rev:ElizabethArdenMemberus-gaap:OperatingSegmentsMember2019-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMember2019-12-310000887921rev:RevlonPortfolioElizabethArdenandFragrancesSegmentsMemberus-gaap:OperatingSegmentsMember2019-12-310000887921rev:MassPortfolioMember2018-10-012018-12-31rev:reporting_unit0000887921us-gaap:TrademarksMember2019-12-310000887921us-gaap:TrademarksMember2019-01-012019-12-310000887921us-gaap:CustomerRelationshipsMember2019-12-310000887921us-gaap:CustomerRelationshipsMember2019-01-012019-12-310000887921us-gaap:PatentsMember2019-12-310000887921us-gaap:PatentsMember2019-01-012019-12-310000887921us-gaap:DistributionRightsMember2019-12-310000887921us-gaap:DistributionRightsMember2019-01-012019-12-310000887921us-gaap:OtherIntangibleAssetsMember2019-12-310000887921us-gaap:OtherIntangibleAssetsMember2019-01-012019-12-310000887921us-gaap:TradeNamesMember2019-12-310000887921us-gaap:TrademarksMember2018-12-310000887921us-gaap:TrademarksMember2018-01-012018-12-310000887921us-gaap:CustomerRelationshipsMember2018-12-310000887921us-gaap:CustomerRelationshipsMember2018-01-012018-12-310000887921us-gaap:PatentsMember2018-12-310000887921us-gaap:PatentsMember2018-01-012018-12-310000887921us-gaap:DistributionRightsMember2018-12-310000887921us-gaap:DistributionRightsMember2018-01-012018-12-310000887921us-gaap:OtherIntangibleAssetsMember2018-12-310000887921us-gaap:OtherIntangibleAssetsMember2018-01-012018-12-310000887921us-gaap:TradeNamesMember2018-12-310000887921rev:TwoThousandNineteenTermLoanFacilityMember2019-12-310000887921rev:TwoThousandNineteenTermLoanFacilityMember2018-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndEighteenMember2019-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndEighteenMember2018-12-310000887921rev:RevolvingCreditFacilityDue2021Member2019-12-310000887921rev:RevolvingCreditFacilityDue2021Member2018-12-310000887921rev:TermLoanFacilityDue2023Member2019-12-310000887921rev:TermLoanFacilityDue2023Member2018-12-310000887921rev:FivePointSevenFivePercentSeniorNotesDueTwoThousandTwentyOneMember2019-12-310000887921rev:FivePointSevenFivePercentSeniorNotesDueTwoThousandTwentyOneMember2018-12-310000887921rev:SenorNotesDue2024Member2019-12-310000887921rev:SenorNotesDue2024Member2018-12-310000887921rev:SpanishGovernmentLoanDue2025Member2019-12-310000887921rev:SpanishGovernmentLoanDue2025Member2018-12-310000887921srt:ScenarioForecastMemberrev:RevolvingCreditFacilityDue2021Member2020-01-012020-12-310000887921rev:TermLoanFacilityDue2023Member2019-01-012019-03-310000887921rev:TwoThousandNineteenTermLoanFacilityMember2019-08-012019-08-310000887921rev:FivePointSevenFivePercentSeniorNotesDueTwoThousandTwentyOneMember2019-08-310000887921rev:TwoThousandNineteenTermLoanFacilityMember2019-08-3100008879212019-08-310000887921srt:MinimumMemberrev:TwoThousandNineteenTermLoanFacilityMember2019-08-310000887921rev:TwoThousandNineteenTermLoanFacilityMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2019-08-310000887921us-gaap:DebtInstrumentRedemptionPeriodTwoMemberrev:TwoThousandNineteenTermLoanFacilityMember2019-08-310000887921rev:TwoThousandNineteenTermLoanFacilityMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2019-08-310000887921rev:TwoThousandNineteenTermLoanFacilityMemberus-gaap:DebtInstrumentRedemptionPeriodFourMember2019-08-310000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2019-08-310000887921rev:TwoThousandNineteenSeniorUnsecuredLineofCreditAgreementMemberus-gaap:LineOfCreditMember2019-06-300000887921rev:TwoThousandNineteenSeniorUnsecuredLineofCreditAgreementMemberus-gaap:LineOfCreditMember2019-11-072019-11-070000887921rev:TwoThousandNineteenSeniorUnsecuredLineofCreditAgreementMemberus-gaap:LineOfCreditMember2019-12-310000887921rev:TwoThousandNineteenSeniorUnsecuredLineofCreditAgreementMemberus-gaap:LineOfCreditMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheBMember2019-03-060000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheBMember2019-03-050000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheBMember2019-03-052019-03-050000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheBMember2019-03-062019-03-06rev:day0000887921us-gaap:RevolvingCreditFacilityMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2018-04-300000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2018-04-300000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheAMember2018-04-300000887921us-gaap:LetterOfCreditMemberrev:TrancheAMember2018-04-300000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheBMember2018-04-300000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheAMember2019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheBMember2019-12-31iso4217:EUR0000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndFourteenMemberus-gaap:SecuredDebtMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndFourteenMemberus-gaap:SecuredDebtMemberus-gaap:EurodollarMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:AmendedAndRestatedSeniorSubordinatedTermLoanDueTwoThousandAndFourteenMemberus-gaap:SecuredDebtMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:TermLoanFacilityDue2023Memberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:TermLoanFacilityDue2023Memberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:ElizabethArdenMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:ElizabethArdenSeniorNotesDue2021Memberrev:ElizabethArdenMember2019-01-012019-12-310000887921rev:ElizabethArdenRevolvingCreditFacilityMemberrev:ElizabethArdenMember2019-12-310000887921rev:ElizabethArdenMemberrev:ElizabethArdenSecondLienCreditFacilityMember2019-01-012019-12-310000887921rev:ElizabethArdenMember2019-01-012019-12-310000887921rev:RevlonConsumerProductsCorporationMemberrev:TermLoanFacilityDue2017Member2019-01-012019-12-310000887921rev:AcquisitionTermLoanFacilityDue2019Memberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:LondonInterbankOfferedRateLIBORMemberrev:TermLoanFacilityDue2023Memberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:TermLoanFacilityDue2023Memberus-gaap:BaseRateMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevolvingCreditFacilityDue2021Memberus-gaap:LetterOfCreditMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMemberus-gaap:BridgeLoanMember2019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2019-12-310000887921rev:AverageExcessAvailabilityThresholdOneMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:AverageExcessAvailabilityThresholdTwoMemberus-gaap:BaseRateMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMemberrev:AverageExcessAvailabilityThresholdThreeMember2019-01-012019-12-310000887921rev:AverageExcessAvailabilityThresholdOneMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:AverageExcessAvailabilityThresholdTwoMemberus-gaap:BaseRateMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMemberrev:AverageExcessAvailabilityThresholdThreeMember2019-01-012019-12-310000887921rev:AverageExcessAvailabilityThresholdOneMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:AverageExcessAvailabilityThresholdTwoMemberus-gaap:EurodollarMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMemberrev:AverageExcessAvailabilityThresholdThreeMember2019-01-012019-12-310000887921rev:AverageExcessAvailabilityThresholdOneMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:AverageExcessAvailabilityThresholdTwoMemberus-gaap:EurodollarMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMemberrev:AverageExcessAvailabilityThresholdThreeMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:TrancheAMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-03-050000887921us-gaap:RevolvingCreditFacilityMemberrev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-03-052019-03-050000887921us-gaap:RevolvingCreditFacilityMemberrev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-03-060000887921us-gaap:RevolvingCreditFacilityMemberrev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2019-03-062019-03-060000887921us-gaap:RevolvingCreditFacilityMemberrev:RevlonConsumerProductsCorporationMemberrev:TrancheBMember2019-03-070000887921rev:FivePointSevenFivePercentSeniorNotesDueTwoThousandTwentyOneMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevlonConsumerProductsCorporationMemberrev:OriginalSeniorNotes5.75Member2013-02-080000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2013-02-080000887921rev:FivePointSevenFivePercentSeniorNotesDueTwoThousandTwentyOneMemberrev:RevlonConsumerProductsCorporationMember2013-12-310000887921rev:FivePointSevenFivePercentSeniorNotesDueTwoThousandTwentyOneMemberrev:RevlonConsumerProductsCorporationMember2013-12-012013-12-310000887921rev:NinePointSevenFivePercentSeniorSecuredNotesDueTwoThousandAndFifteenMemberrev:RevlonConsumerProductsCorporationMember2013-12-012013-12-310000887921rev:NinePointSevenFivePercentSeniorSecuredNotesDueTwoThousandAndFifteenMemberrev:RevlonConsumerProductsCorporationMember2013-12-310000887921rev:RevlonConsumerProductsCorporationMemberrev:TermLoanFacilityDue2017Member2013-02-082013-02-080000887921rev:FivePointSevenFivePercentSeniorNotesDueTwoThousandTwentyOneMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2016-08-040000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2016-12-310000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2019-01-012019-12-310000887921us-gaap:DebtInstrumentRedemptionPeriodTwoMemberrev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2019-01-012019-12-310000887921rev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:RevolvingCreditFacilityDue2021Member2019-12-310000887921rev:A2019SeniorLineofCreditMember2019-12-310000887921us-gaap:LetterOfCreditMemberrev:TrancheAMember2019-12-310000887921rev:ForeignSubsidiariesMember2019-12-310000887921rev:TermLoanFacilityDue2023Member2019-01-012019-12-310000887921us-gaap:RevolvingCreditFacilityMemberrev:TermLoanFacilityDue2023Member2019-12-310000887921us-gaap:FairValueInputsLevel1Member2019-12-310000887921us-gaap:FairValueInputsLevel2Member2019-12-310000887921us-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel1Member2018-12-310000887921us-gaap:FairValueInputsLevel2Member2018-12-310000887921us-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:LetterOfCreditMember2019-12-310000887921us-gaap:LetterOfCreditMember2018-12-310000887921rev:StandbyLettersOfCreditWhichSupportProductsCorporationsSelfInsuranceProgramsMember2019-12-310000887921rev:StandbyLettersOfCreditWhichSupportProductsCorporationsSelfInsuranceProgramsMember2018-12-310000887921us-gaap:ForeignExchangeContractMember2019-01-012019-12-31rev:contract0000887921us-gaap:ForeignExchangeContractMember2018-12-310000887921us-gaap:InterestRateSwapMember2013-11-300000887921us-gaap:InterestRateSwapMember2016-12-310000887921us-gaap:InterestRateSwapMember2016-12-012016-12-310000887921rev:SenorNotesDue2024Member2016-09-070000887921us-gaap:InterestRateSwapMember2016-09-070000887921us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2016-09-070000887921us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2019-01-012019-12-310000887921us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2018-01-012018-12-310000887921us-gaap:ForeignExchangeContractMemberus-gaap:ForeignCurrencyGainLossMember2019-01-012019-12-310000887921us-gaap:ForeignExchangeContractMemberus-gaap:ForeignCurrencyGainLossMember2018-01-012018-12-310000887921us-gaap:InterestRateSwapMemberus-gaap:OtherNonoperatingIncomeExpenseMember2019-01-012019-12-310000887921us-gaap:InterestRateSwapMemberus-gaap:OtherNonoperatingIncomeExpenseMember2018-01-012018-12-310000887921us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2019-01-012019-12-310000887921us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2018-01-012018-12-310000887921rev:SavingsPlanMemberrev:NonHighlyCompensatedParticipantsMember2019-01-012019-12-310000887921rev:SavingsPlanMemberrev:HighlyCompensatedParticipantsMember2019-01-012019-12-310000887921rev:SavingsPlanMember2019-01-012019-12-310000887921rev:SavingsPlanMember2018-01-012018-12-310000887921rev:SavingsPlanMemberus-gaap:SubsequentEventMember2020-01-012020-01-310000887921rev:SavingsPlanMember2019-01-012019-01-31rev:plan00008879212012-12-312012-12-310000887921us-gaap:PensionPlansDefinedBenefitMember2018-12-310000887921us-gaap:PensionPlansDefinedBenefitMember2017-12-310000887921us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2018-12-310000887921us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2017-12-310000887921us-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310000887921us-gaap:PensionPlansDefinedBenefitMember2018-01-012018-12-310000887921us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310000887921us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2018-01-012018-12-310000887921us-gaap:PensionPlansDefinedBenefitMember2019-12-310000887921us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-310000887921rev:RelatedPartyTransactionPensionPlanLiabilitiesMember2019-12-310000887921rev:RelatedPartyTransactionPensionPlanLiabilitiesMember2018-12-310000887921us-gaap:CostOfSalesMember2019-01-012019-12-310000887921us-gaap:CostOfSalesMember2018-01-012018-12-310000887921us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310000887921us-gaap:SellingGeneralAndAdministrativeExpensesMember2018-01-012018-12-310000887921rev:MiscellaneousNetMember2019-01-012019-12-310000887921rev:MiscellaneousNetMember2018-01-012018-12-310000887921country:US2019-12-310000887921country:US2018-12-310000887921us-gaap:ForeignPlanMember2019-12-310000887921us-gaap:ForeignPlanMember2018-12-310000887921country:US2019-01-012019-12-310000887921country:US2018-01-012018-12-310000887921us-gaap:ForeignPlanMember2019-01-012019-12-310000887921us-gaap:ForeignPlanMember2018-01-012018-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMembercountry:USsrt:MinimumMember2019-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMembercountry:USsrt:MaximumMember2019-12-310000887921us-gaap:ForeignPlanMemberus-gaap:DefinedBenefitPlanEquitySecuritiesMember2019-12-310000887921us-gaap:MutualFundMembercountry:USsrt:MinimumMember2019-12-310000887921us-gaap:MutualFundMembercountry:USsrt:MaximumMember2019-12-310000887921us-gaap:ForeignPlanMemberus-gaap:MutualFundMember2019-12-310000887921country:USsrt:MinimumMemberus-gaap:DefinedBenefitPlanDebtSecurityMember2019-12-310000887921country:USsrt:MaximumMemberus-gaap:DefinedBenefitPlanDebtSecurityMember2019-12-310000887921us-gaap:ForeignPlanMemberus-gaap:DefinedBenefitPlanDebtSecurityMember2019-12-310000887921country:USsrt:MinimumMemberus-gaap:DefinedBenefitPlanCommonCollectiveTrustMember2019-12-310000887921country:USsrt:MaximumMemberus-gaap:DefinedBenefitPlanCommonCollectiveTrustMember2019-12-310000887921us-gaap:ForeignPlanMemberus-gaap:DefinedBenefitPlanCommonCollectiveTrustMember2019-12-310000887921us-gaap:HedgeFundsMembercountry:USsrt:MinimumMember2019-12-310000887921us-gaap:HedgeFundsMembercountry:USsrt:MaximumMember2019-12-310000887921us-gaap:ForeignPlanMemberus-gaap:HedgeFundsMember2019-12-310000887921country:USsrt:MinimumMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310000887921country:USsrt:MaximumMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310000887921us-gaap:ForeignPlanMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2019-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:FixedIncomeFundsCorporateMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:FixedIncomeFundsCorporateMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:FixedIncomeFundsCorporateMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:FixedIncomeFundsCorporateMember2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:FixedIncomeFundsGovernmentMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:FixedIncomeFundsGovernmentMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:FixedIncomeFundsGovernmentMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:FixedIncomeFundsGovernmentMember2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsUSLargeCapMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsUSLargeCapMember2019-12-310000887921rev:EquityFundsUSLargeCapMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:EquityFundsUSLargeCapMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsNonUSNonEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsNonUSNonEmergingMarketsMember2019-12-310000887921rev:EquityFundsNonUSNonEmergingMarketsMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:EquityFundsNonUSNonEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsNonUSEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsNonUSEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:EquityFundsNonUSEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:EquityFundsNonUSEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsCashandCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsCashandCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:EquityFundsCashandCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:EquityFundsCashandCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:OtherFundsMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:OtherFundsMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:OtherFundsMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:OtherFundsMember2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberus-gaap:CorporateDebtSecuritiesMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2019-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel1Member2019-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMember2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel1Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMember2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMember2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustOtherMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustOtherMember2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustOtherMemberus-gaap:FairValueInputsLevel2Member2019-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustOtherMemberus-gaap:FairValueInputsLevel3Member2019-12-310000887921us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310000887921us-gaap:FairValueInputsLevel12And3Member2019-12-310000887921us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000887921us-gaap:HedgeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000887921us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2018-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2018-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:FixedIncomeFundsCorporateMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:FixedIncomeFundsCorporateMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:FixedIncomeFundsCorporateMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:FixedIncomeFundsCorporateMember2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:FixedIncomeFundsGovernmentMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:FixedIncomeFundsGovernmentMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:FixedIncomeFundsGovernmentMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:FixedIncomeFundsGovernmentMember2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsUSLargeCapMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsUSLargeCapMember2018-12-310000887921rev:EquityFundsUSLargeCapMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:EquityFundsUSLargeCapMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsNonUSNonEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsNonUSNonEmergingMarketsMember2018-12-310000887921rev:EquityFundsNonUSNonEmergingMarketsMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:EquityFundsNonUSNonEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsNonUSEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsNonUSEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:EquityFundsNonUSEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:EquityFundsNonUSEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:EquityFundsCashandCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:EquityFundsCashandCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:EquityFundsCashandCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:EquityFundsCashandCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:OtherFundsMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:OtherFundsMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:OtherFundsMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:OtherFundsMember2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberus-gaap:CorporateDebtSecuritiesMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2018-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel12And3Member2018-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel1Member2018-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DebtSecurityGovernmentMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMember2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel12And3Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel1Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSLargeCapMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMember2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesUSSmallandMidCapMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMember2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSNonEmergingMarketsMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberrev:DefinedBenefitPlansCommonCollectiveTrustEquitySecuritiesNonUSEmergingMarketsMember2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel12And3Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustCashandCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberrev:DefinedBenefitPlansCommonCollectiveTrustOtherMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberrev:DefinedBenefitPlansCommonCollectiveTrustOtherMember2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustOtherMemberus-gaap:FairValueInputsLevel2Member2018-12-310000887921rev:DefinedBenefitPlansCommonCollectiveTrustOtherMemberus-gaap:FairValueInputsLevel3Member2018-12-310000887921us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2018-12-310000887921us-gaap:FairValueInputsLevel12And3Member2018-12-310000887921us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2018-12-310000887921us-gaap:HedgeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2018-12-310000887921us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2018-12-3100008879212019-08-152019-08-1500008879212019-08-162019-08-1600008879212019-08-160000887921rev:FourthAmendedandRestatedRevlonInc.StockPlanMember2019-01-012019-12-310000887921rev:FourthAmendedandRestatedRevlonInc.StockPlanMember2018-12-310000887921rev:FourthAmendedandRestatedRevlonInc.StockPlanMember2019-12-310000887921rev:RestrictedStockandRestrictedStockUnitsMember2017-12-310000887921rev:RestrictedStockandRestrictedStockUnitsMember2018-01-012018-12-310000887921rev:RestrictedStockandRestrictedStockUnitsMember2018-12-310000887921rev:RestrictedStockandRestrictedStockUnitsMember2019-01-012019-12-310000887921rev:RestrictedStockandRestrictedStockUnitsMember2019-12-310000887921us-gaap:RestrictedStockMemberrev:FourthAmendedandRestatedRevlonInc.StockPlanMember2018-01-012018-12-310000887921rev:LongTermIncentiveProgramMemberus-gaap:RestrictedStockUnitsRSUMember2018-01-012018-12-310000887921us-gaap:RestrictedStockMemberrev:FourthAmendedandRestatedRevlonInc.StockPlanMember2019-01-012019-12-310000887921rev:LongTermIncentiveProgramMemberus-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-310000887921us-gaap:RestrictedStockMember2018-01-012018-12-310000887921us-gaap:RestrictedStockMemberrev:Revlon2019TransactionincentiveprogramMember2019-01-012019-12-310000887921us-gaap:RestrictedStockMemberrev:LongTermIncentiveProgramMember2019-01-012019-12-310000887921us-gaap:RestrictedStockMember2019-01-012019-12-310000887921us-gaap:RestrictedStockMember2019-12-310000887921us-gaap:RestrictedStockMemberrev:FourthAmendedandRestatedRevlonInc.StockPlanMember2019-12-310000887921us-gaap:RestrictedStockMemberrev:LongTermIncentiveProgramMember2019-12-310000887921us-gaap:RestrictedStockMemberrev:LongTermIncentiveProgramMember2018-01-012018-12-310000887921us-gaap:RestrictedStockMemberrev:Revlon2019TransactionincentiveprogramMemberrev:OtherDeferredCompensationArrangementsAnnualPaymentTerm1Member2019-09-050000887921us-gaap:RestrictedStockMemberrev:Revlon2019TransactionincentiveprogramMemberrev:OtherDeferredCompensationArrangementsAnnualPaymentTerm1Member2019-01-012019-12-310000887921rev:Revlon2019TransactionincentiveprogramMemberrev:OtherDeferredCompensationArrangementsAnnualPaymentTerm1Member2019-12-310000887921rev:OtherDeferredCompensationArrangementsAnnualPaymentTerm2Memberrev:Revlon2019TransactionincentiveprogramMember2019-12-310000887921rev:Revlon2019TransactionincentiveprogramMemberrev:OtherDeferredCompensationArrangementsAnnualPaymentTerm1Member2019-01-012019-12-310000887921rev:OtherDeferredCompensationArrangementsAnnualPaymentTerm2Memberrev:Revlon2019TransactionincentiveprogramMember2019-01-012019-12-310000887921rev:AcquisitionIntegrationAndDivestitureCostsMemberrev:Revlon2019TransactionincentiveprogramMemberrev:OtherDeferredCompensationArrangementsAnnualPaymentTerm1Member2019-01-012019-12-310000887921rev:A2018LongTermIncentiveProgramMemberrev:TimebasedandPerformancebasedRSUAwardsMember2019-01-012019-12-310000887921rev:TimebasedandPerformancebasedRSUAwardsMemberrev:Revlon2019TransactionincentiveprogramMember2019-01-012019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2018Member2018-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2018Member2018-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2017Member2018-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2017Member2018-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMember2018-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMember2018-12-310000887921rev:TIPPlanMemberrev:Revlon2019TransactionincentiveprogramMemberrev:AwardsGranted2019Member2019-01-012019-12-310000887921rev:TIPPlanMemberrev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:AwardsGranted2019Member2019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2019Member2019-01-012019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2019Member2019-01-012019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMember2019-01-012019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMember2019-01-012019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2018Member2019-01-012019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2018Member2019-01-012019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2017Member2019-01-012019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2017Member2019-01-012019-12-310000887921rev:TIPPlanMemberrev:Revlon2019TransactionincentiveprogramMemberrev:AwardsGranted2019Member2019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2019Member2019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2019Member2019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2018Member2019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2018Member2019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2017Member2019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMemberrev:AwardsGranted2017Member2019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMember2019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:LTIPPlanMember2019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:TotalLTIPandTIPRSUsMember2019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMemberrev:TotalLTIPandTIPRSUsMember2019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMember2019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMember2019-12-310000887921rev:PerformanceBasedRestrictedStockUnitsRSUAwardsMember2019-01-012019-12-3100008879212014-07-012014-07-310000887921rev:A2018LongTermIncentiveProgramMemberrev:TimeBasedRestrictedStockUnitsRSUAwardsMember2019-01-012019-12-310000887921rev:A2018LongTermIncentiveProgramMemberrev:PerformanceBasedRestrictedStockUnitsRSUAwardsMember2019-01-012019-12-310000887921rev:TimeBasedRestrictedStockUnitsRSUAwardsMemberrev:AwardsGranted2017Member2019-01-012019-12-310000887921us-gaap:ForeignCountryMember2019-12-310000887921country:US2019-12-310000887921srt:AffiliatedEntityMember2019-12-310000887921rev:TaxPaymentMember2019-12-310000887921rev:MacAndrewsForbesTaxSharingAgreementMemberrev:RevlonConsumerProductsCorporationMemberus-gaap:TaxYear2018Member2019-01-012019-12-310000887921rev:MacAndrewsForbesTaxSharingAgreementMemberrev:RevlonConsumerProductsCorporationMemberus-gaap:TaxYear2019Member2019-01-012019-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:TaxYear2019Memberrev:RevlonTaxSharingAgreementMember2019-01-012019-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:TaxYear2018Memberrev:RevlonTaxSharingAgreementMember2019-01-012019-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:TaxYear2017Memberrev:RevlonTaxSharingAgreementMember2018-01-012018-12-310000887921rev:RevlonConsumerProductsCorporationMemberus-gaap:TaxYear2018Memberrev:RevlonTaxSharingAgreementMember2018-01-012018-12-310000887921srt:ScenarioForecastMemberrev:RevlonConsumerProductsCorporationMemberus-gaap:TaxYear2019Memberrev:RevlonTaxSharingAgreementMember2020-01-012020-12-310000887921us-gaap:AccumulatedTranslationAdjustmentMember2017-12-310000887921us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2017-12-310000887921us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2017-12-310000887921rev:AccumulatedOtherComprehensiveIncomeLossOtherAttributabletoParentMember2017-12-310000887921us-gaap:AccumulatedTranslationAdjustmentMember2018-01-012018-12-310000887921us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-01-012018-12-310000887921us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-01-012018-12-310000887921rev:AccumulatedOtherComprehensiveIncomeLossOtherAttributabletoParentMember2018-01-012018-12-310000887921us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310000887921us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310000887921us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-12-310000887921rev:AccumulatedOtherComprehensiveIncomeLossOtherAttributabletoParentMember2018-12-310000887921us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310000887921us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310000887921us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-01-012019-12-310000887921us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-01-012019-12-310000887921rev:AccumulatedOtherComprehensiveIncomeLossOtherAttributabletoParentMember2019-01-012019-12-310000887921us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000887921us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310000887921us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310000887921rev:AccumulatedOtherComprehensiveIncomeLossOtherAttributabletoParentMember2019-12-310000887921us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2017-12-310000887921us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2018-01-012018-12-310000887921us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2018-12-310000887921us-gaap:CommonStockMemberus-gaap:CommonClassAMember2017-12-310000887921us-gaap:CommonStockMemberus-gaap:CommonClassAMember2018-01-012018-12-310000887921us-gaap:CommonStockMemberus-gaap:CommonClassAMember2018-12-310000887921us-gaap:CommonStockMemberus-gaap:CommonClassAMember2019-01-012019-12-310000887921us-gaap:CommonStockMemberus-gaap:CommonClassAMember2019-12-310000887921us-gaap:CommonClassAMember2019-12-310000887921us-gaap:CommonClassBMember2019-12-310000887921us-gaap:RestrictedStockMemberus-gaap:TreasuryStockMemberus-gaap:CommonClassAMember2018-01-012018-12-310000887921us-gaap:RestrictedStockMemberus-gaap:CommonClassAMember2018-01-012018-12-310000887921us-gaap:RestrictedStockMemberus-gaap:TreasuryStockMember2018-01-012018-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMember2018-01-012018-12-310000887921us-gaap:OperatingSegmentsMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMember2018-01-012018-12-310000887921us-gaap:MaterialReconcilingItemsMember2019-01-012019-12-310000887921us-gaap:MaterialReconcilingItemsMember2018-01-012018-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMemberrev:RevlonSegmentMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMemberrev:RevlonSegmentMember2018-01-012018-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMemberrev:PortfolioSegmentMember2018-01-012018-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:FragrancesSegmentMemberus-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:OperatingSegmentsMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921us-gaap:MaterialReconcilingItemsMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921us-gaap:MaterialReconcilingItemsMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-31rev:country0000887921us-gaap:NonUsMember2019-12-310000887921us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberrev:WalmartMember2019-01-012019-12-310000887921us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberrev:WalmartMember2018-01-012018-12-310000887921srt:NorthAmericaMemberrev:RevlonSegmentMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMembersrt:NorthAmericaMember2019-01-012019-12-310000887921srt:NorthAmericaMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921rev:FragrancesSegmentMembersrt:NorthAmericaMember2019-01-012019-12-310000887921srt:NorthAmericaMember2019-01-012019-12-310000887921us-gaap:EMEAMemberrev:RevlonSegmentMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:EMEAMember2019-01-012019-12-310000887921us-gaap:EMEAMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921rev:FragrancesSegmentMemberus-gaap:EMEAMember2019-01-012019-12-310000887921us-gaap:EMEAMember2019-01-012019-12-310000887921srt:AsiaMemberrev:RevlonSegmentMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMembersrt:AsiaMember2019-01-012019-12-310000887921srt:AsiaMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921srt:AsiaMemberrev:FragrancesSegmentMember2019-01-012019-12-310000887921srt:AsiaMember2019-01-012019-12-310000887921srt:LatinAmericaMemberrev:RevlonSegmentMember2019-01-012019-12-310000887921srt:LatinAmericaMemberrev:ElizabethArdenSegmentMember2019-01-012019-12-310000887921srt:LatinAmericaMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921srt:LatinAmericaMemberrev:FragrancesSegmentMember2019-01-012019-12-310000887921srt:LatinAmericaMember2019-01-012019-12-310000887921rev:PacificMemberrev:RevlonSegmentMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMemberrev:PacificMember2019-01-012019-12-310000887921rev:PacificMemberrev:PortfolioSegmentMember2019-01-012019-12-310000887921rev:FragrancesSegmentMemberrev:PacificMember2019-01-012019-12-310000887921rev:PacificMember2019-01-012019-12-310000887921rev:RevlonSegmentMember2019-01-012019-12-310000887921rev:ElizabethArdenSegmentMember2019-01-012019-12-310000887921rev:PortfolioSegmentMember2019-01-012019-12-310000887921rev:FragrancesSegmentMember2019-01-012019-12-310000887921srt:NorthAmericaMemberrev:RevlonSegmentMember2018-01-012018-12-310000887921rev:ElizabethArdenSegmentMembersrt:NorthAmericaMember2018-01-012018-12-310000887921srt:NorthAmericaMemberrev:PortfolioSegmentMember2018-01-012018-12-310000887921rev:FragrancesSegmentMembersrt:NorthAmericaMember2018-01-012018-12-310000887921srt:NorthAmericaMember2018-01-012018-12-310000887921us-gaap:EMEAMemberrev:RevlonSegmentMember2018-01-012018-12-310000887921rev:ElizabethArdenSegmentMemberus-gaap:EMEAMember2018-01-012018-12-310000887921us-gaap:EMEAMemberrev:PortfolioSegmentMember2018-01-012018-12-310000887921rev:FragrancesSegmentMemberus-gaap:EMEAMember2018-01-012018-12-310000887921us-gaap:EMEAMember2018-01-012018-12-310000887921srt:AsiaMemberrev:RevlonSegmentMember2018-01-012018-12-310000887921rev:ElizabethArdenSegmentMembersrt:AsiaMember2018-01-012018-12-310000887921srt:AsiaMemberrev:PortfolioSegmentMember2018-01-012018-12-310000887921srt:AsiaMemberrev:FragrancesSegmentMember2018-01-012018-12-310000887921srt:AsiaMember2018-01-012018-12-310000887921srt:LatinAmericaMemberrev:RevlonSegmentMember2018-01-012018-12-310000887921srt:LatinAmericaMemberrev:ElizabethArdenSegmentMember2018-01-012018-12-310000887921srt:LatinAmericaMemberrev:PortfolioSegmentMember2018-01-012018-12-310000887921srt:LatinAmericaMemberrev:FragrancesSegmentMember2018-01-012018-12-310000887921srt:LatinAmericaMember2018-01-012018-12-310000887921rev:PacificMemberrev:RevlonSegmentMember2018-01-012018-12-310000887921rev:ElizabethArdenSegmentMemberrev:PacificMember2018-01-012018-12-310000887921rev:PacificMemberrev:PortfolioSegmentMember2018-01-012018-12-310000887921rev:FragrancesSegmentMemberrev:PacificMember2018-01-012018-12-310000887921rev:PacificMember2018-01-012018-12-310000887921rev:RevlonSegmentMember2018-01-012018-12-310000887921rev:ElizabethArdenSegmentMember2018-01-012018-12-310000887921rev:PortfolioSegmentMember2018-01-012018-12-310000887921rev:FragrancesSegmentMember2018-01-012018-12-310000887921rev:ColorCosmeticsMember2019-01-012019-12-310000887921rev:ColorCosmeticsMember2018-01-012018-12-310000887921rev:FragrancesSegmentMember2019-01-012019-12-310000887921rev:FragrancesSegmentMember2018-01-012018-12-310000887921rev:HaircareMember2019-01-012019-12-310000887921rev:HaircareMember2018-01-012018-12-310000887921rev:BeautyCareMember2019-01-012019-12-310000887921rev:BeautyCareMember2018-01-012018-12-310000887921rev:SkinCareMember2019-01-012019-12-310000887921rev:SkinCareMember2018-01-012018-12-310000887921country:US2019-12-310000887921country:US2018-12-310000887921us-gaap:NonUsMember2018-12-310000887921rev:RestrictedStockandRestrictedStockUnitsMember2019-01-012019-12-310000887921rev:RestrictedStockandRestrictedStockUnitsMember2018-01-012018-12-310000887921rev:RevlonHoldingsMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921rev:RevlonHoldingsMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:RevlonHoldingsMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevlonHoldingsMemberrev:RevlonConsumerProductsCorporationMember2018-12-310000887921rev:RevlonHoldingsMember2019-01-012019-12-310000887921rev:RevlonHoldingsMember2018-01-012018-12-310000887921rev:RevlonHoldingsMember2019-12-310000887921rev:RevlonHoldingsMember2018-12-310000887921rev:ReimbursementsMember2019-01-012019-12-310000887921rev:ReimbursementsMember2018-01-012018-12-310000887921rev:MacAndrewsForbesMemberrev:ReimbursementsMember2019-12-310000887921rev:ReimbursementsMember2018-12-310000887921rev:RegistrationRightsAgreementMemberrev:TwoThousandThreeMember2013-10-310000887921us-gaap:CommonClassAMember2013-10-012013-10-310000887921rev:TwoThousandSixMemberrev:RegistrationRightsAgreementMember2006-03-310000887921rev:TwoThousandSevenMemberrev:RegistrationRightsAgreementMember2007-01-310000887921us-gaap:CommonClassAMember2009-01-012009-12-3100008879212009-01-012009-12-310000887921srt:SubsidiariesMember2019-01-012019-12-310000887921rev:RelatedPartyExpenseOtherAdvertisingCouponRedemptionandRawMaterialSupplyServicesMemberus-gaap:MajorityShareholderMember2019-01-012019-12-310000887921rev:RelatedPartyExpenseOtherAdvertisingCouponRedemptionandRawMaterialSupplyServicesMemberus-gaap:MajorityShareholderMember2018-01-012018-12-310000887921rev:RelatedPartyExpenseOtherAdvertisingCouponRedemptionandRawMaterialSupplyServicesMemberus-gaap:MajorityShareholderMember2019-12-310000887921rev:RelatedPartyExpenseOtherAdvertisingCouponRedemptionandRawMaterialSupplyServicesMemberus-gaap:MajorityShareholderMember2018-12-310000887921rev:ReimbursementsMember2019-12-310000887921srt:DirectorMember2019-01-012019-12-310000887921srt:DirectorMember2018-01-012018-12-310000887921rev:DirectorTwoMember2019-01-012019-12-310000887921srt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921srt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921srt:NonGuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-12-310000887921rev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2019-12-310000887921srt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-12-310000887921srt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-12-310000887921srt:NonGuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-12-310000887921rev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2018-12-310000887921srt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921srt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921srt:NonGuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2019-01-012019-12-310000887921srt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921srt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921srt:NonGuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921rev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2018-01-012018-12-310000887921rev:RevolvingCreditFacilityDue2021Membersrt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:RevolvingCreditFacilityDue2021Membersrt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921srt:NonGuarantorSubsidiariesMemberrev:RevolvingCreditFacilityDue2021Membersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2019-01-012019-12-310000887921srt:SubsidiariesMemberrev:TwoThousandNineteenTermLoanFacilityMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921srt:GuarantorSubsidiariesMemberrev:TwoThousandNineteenTermLoanFacilityMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921srt:NonGuarantorSubsidiariesMemberrev:TwoThousandNineteenTermLoanFacilityMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2019-01-012019-12-310000887921rev:TwoThousandNineteenTermLoanFacilityMemberrev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2019-01-012019-12-310000887921rev:RevolvingCreditFacilityDue2021Membersrt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921rev:RevolvingCreditFacilityDue2021Membersrt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921srt:NonGuarantorSubsidiariesMemberrev:RevolvingCreditFacilityDue2021Membersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921rev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2018-01-012018-12-310000887921rev:RevolvingCreditFacilityDue2021Memberrev:RevlonConsumerProductsCorporationMember2018-01-012018-12-310000887921srt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMemberrev:ForeignAssetBasedTermLoanTwoThousandEighteenMember2018-01-012018-12-310000887921srt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMemberrev:ForeignAssetBasedTermLoanTwoThousandEighteenMember2018-01-012018-12-310000887921srt:NonGuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMemberrev:ForeignAssetBasedTermLoanTwoThousandEighteenMember2018-01-012018-12-310000887921rev:RevlonConsumerProductsCorporationMemberrev:ForeignAssetBasedTermLoanTwoThousandEighteenMembersrt:ConsolidationEliminationsMember2018-01-012018-12-310000887921rev:RevlonConsumerProductsCorporationMemberrev:ForeignAssetBasedTermLoanTwoThousandEighteenMember2018-01-012018-12-310000887921srt:SubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2017-12-310000887921srt:GuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2017-12-310000887921srt:NonGuarantorSubsidiariesMembersrt:ReportableLegalEntitiesMemberrev:RevlonConsumerProductsCorporationMember2017-12-310000887921rev:RevlonConsumerProductsCorporationMembersrt:ConsolidationEliminationsMember2017-12-310000887921us-gaap:LetterOfCreditMemberrev:JefferiesFinanceLLCCommitmentLetterMemberrev:RevlonConsumerProductsCorporationMemberus-gaap:SubsequentEventMember2020-03-100000887921us-gaap:LetterOfCreditMemberrev:RevlonConsumerProductsCorporationMemberrev:SeniorTermLoanFacilityBrandcoFacilityMemberus-gaap:SubsequentEventMember2020-03-100000887921us-gaap:LetterOfCreditMemberrev:RevlonConsumerProductsCorporationMemberus-gaap:SubsequentEventMemberrev:SeniorTermLoanFacilitySpecifiedBrandsFacilityMember2020-03-100000887921srt:ScenarioForecastMemberrev:SenorNotesDue2024Memberrev:RevlonConsumerProductsCorporationMember2020-03-100000887921rev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2020-03-012020-03-100000887921srt:ScenarioForecastMemberrev:EmployeeSeveranceRetentionAndOtherContractualTerminationBenefitsMembersrt:MinimumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2020-12-310000887921srt:ScenarioForecastMemberrev:EmployeeSeveranceRetentionAndOtherContractualTerminationBenefitsMembersrt:MaximumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2020-12-310000887921srt:ScenarioForecastMemberrev:EmployeeSeveranceRetentionAndOtherContractualTerminationBenefitsMembersrt:MinimumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2022-12-310000887921srt:ScenarioForecastMemberrev:EmployeeSeveranceRetentionAndOtherContractualTerminationBenefitsMembersrt:MaximumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2022-12-310000887921srt:ScenarioForecastMemberrev:EmployeeSeveranceRetentionAndOtherContractualTerminationBenefitsMembersrt:MinimumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2021-12-310000887921srt:ScenarioForecastMemberrev:EmployeeSeveranceRetentionAndOtherContractualTerminationBenefitsMembersrt:MaximumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2021-12-310000887921srt:ScenarioForecastMembersrt:MinimumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2020-01-012022-12-310000887921srt:ScenarioForecastMembersrt:MaximumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2020-01-012022-12-310000887921srt:ScenarioForecastMembersrt:MinimumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2020-01-012020-12-310000887921srt:ScenarioForecastMembersrt:MaximumMemberrev:Revlon2020RestructuringPlanMemberus-gaap:SubsequentEventMember2020-01-012020-12-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 10-K
(Mark One)
 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2019
OR
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from__________________ to _______________

Commission File NumberRegistrant; State of Incorporation; Address and Telephone NumberIRS Employer Identification No.
1-11178Revlon, Inc.13-3662955
Delaware
One New York Plaza
New York, New York 10004
212-527-4000
33-59560Revlon Consumer Products Corporation13-3662953
Delaware
One New York Plaza
New York, New York 10004
212-527-4000
Securities registered pursuant to Section 12(b) or 12(g) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Revlon, Inc.Class A Common StockREVNew York Stock Exchange
Revlon Consumer Products CorporationNoneN/AN/A

Indicate by check mark if the registrants are a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No

Indicate by check mark whether the registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.
Revlon, Inc.
Yes
No
Revlon Consumer Products Corporation
Yes
No


Indicate by check mark whether the registrants have submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No ¨


Indicate by check mark whether each registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
1


Large accelerated filer Accelerated filer Non-accelerated filer Smaller Reporting CompanyEmerging Growth Company
Revlon, Inc.
Yes No
Yes No
Yes No
Yes No
Yes No
Revlon Consumer Products Corporation
Yes No
Yes No
Yes No
Yes No
Yes No
If an emerging growth company, indicate by check mark if the registrants have elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨


Indicate by check mark whether each registrant is a shell company (as defined in Rule 12b-2 of the Act).
Revlon, Inc.
Yes
No
Revlon Consumer Products Corporation
Yes
No


The aggregate market value of Revlon, Inc. Class A Common Stock held by non-affiliates (using the New York Stock Exchange closing price as of June 28, 2019, the last business day of the registrant's most recently completed second fiscal quarter) was approximately $131,677,719. Accordingly, the registrant qualifies under the SEC's revised rules as a "smaller reporting company."

Number of shares of common stock outstanding as of December 31, 2019:
Revlon, Inc. Class A Common Stock: 53,069,832  
Revlon Consumer Products Corporation Common Stock:5,260  

At such date, (i) 46,223,321 shares of Revlon, Inc. Class A Common Stock were beneficially owned by MacAndrews & Forbes Incorporated and certain of its affiliates; and (ii) all shares of Revlon Consumer Products Corporation Common Stock were held by Revlon, Inc.

Revlon Consumer Products Corporation meets the conditions set forth in General Instructions I(1)(a) and (b) of Form 10-K as, among other things, all of Revlon Consumer Products Corporation's equity securities are owned directly by Revlon, Inc., which is a reporting company under the Securities Exchange Act of 1934 and which has filed with the SEC on March 12, 2020 all of the material required to be filed pursuant to Section 13, 14, or 15(d) thereof. Revlon Consumer Products Corporation is therefore filing this Form 10-K with a reduced disclosure format, which omits the information otherwise required by Items 10, 11, 12 and 13 as permitted under General Instruction I(2)(c) of Form 10-K.

DOCUMENTS INCORPORATED BY REFERENCE
Portions of Revlon, Inc.’s definitive Proxy Statement to be delivered to stockholders in connection with its Annual Stockholders' Meeting to be held on or about June 4, 2020 are incorporated by reference into Part III of this Form 10-K.
2


REVLON, INC. AND SUBSIDIARIES
REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES
For the Year Ended December 31, 2019
INDEX

PART I
Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.
PART II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
PART III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
PART IV
Item 15.
Item 16.
Certifications
Exhibits



3

Table of Contents

REVLON, INC. AND SUBSIDIARIES
PART I - FINANCIAL INFORMATION

Item 1. Business

Background
Revlon, Inc. ("Revlon" and together with its subsidiaries, the "Company") conducts its business exclusively through its direct wholly-owned operating subsidiary, Revlon Consumer Products Corporation ("Products Corporation") and its subsidiaries. Revlon is an indirect majority-owned subsidiary of MacAndrews & Forbes Incorporated (together with certain of its affiliates other than the Company, "MacAndrews & Forbes"), a corporation beneficially owned by Ronald O. Perelman. Mr. Perelman is Chairman of Revlon's and Products Corporation's Board of Directors.
The Company was founded over 88 years ago by Charles Revson, who revolutionized the cosmetics industry by introducing nail enamels matched to lipsticks in fashion colors. Today, the Company continues Revson's legacy by producing and marketing innovative products that address consumers' wants and needs for beauty and personal care products.
The Company is a leading global beauty company with an iconic portfolio of brands. The Company develops, manufactures, markets, distributes and sells worldwide an extensive array of beauty and personal care products, including color cosmetics, hair color, hair care and hair treatments, fragrances, skin care, beauty tools, men’s grooming products, anti-perspirant deodorants and other beauty care products across a variety of distribution channels. The Company is entrepreneurial, agile and boldly creative, with a passion for beauty. The Company has a diverse portfolio of iconic brands that it continues to evolve and transform, with the goal of inspiring and attracting consumers around the world wherever and however they shop for beauty. The Company is committed to operating as an ethical business and driving sustainable and responsible growth.

Business Strategy
The Company remains focused on its 3 key strategic pillars to drive its future success and growth. First, strengthening its iconic brands through innovation and relevant product portfolios; second, building its capabilities to better communicate and connect with its consumers through media channels where they spend the most time; and third, ensuring availability of its products where consumers shop, both in-store and increasingly online.

Strategic Review
In August 2019, it was disclosed that MacAndrews & Forbes and the Company determined to explore strategic transactions involving the Company and third parties. This review is ongoing and remains focused on exploring potential options for the Company's portfolio and regional brands (the “Strategic Review”).

Financial Information about Operating Segments
Operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the Company's "Chief Executive Officer") in deciding how to allocate resources and in assessing the Company's performance. As a result of the similarities in the procurement, manufacturing and distribution processes for the Company’s products, much of the information provided in the Audited Consolidated Financial Statements and provided in the segment table below is similar to, or the same as, that reviewed on a regular basis by the Company's Chief Executive Officer. The Company operates in four brand-centric reporting units that are aligned with its organizational structure based on four global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances. The Company manufactures, markets and sells an extensive array of beauty and personal care products worldwide, including color cosmetics; fragrances; skin care; hair color, hair care and hair treatments; beauty tools; men's grooming products; anti-perspirant deodorants; and other beauty care products.
As of December 31, 2019, the Company’s operations are organized into the following reportable segments:
Revlon - The Revlon segment is comprised of the Company's flagship Revlon brands. Revlon segment products are primarily marketed, distributed and sold in the mass retail channel, large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department stores, professional hair and nail salons, one-stop shopping beauty retailers and specialty cosmetic stores in the U.S. and internationally under brands such as Revlon in color cosmetics; Revlon ColorSilk and Revlon Professional in hair color; and Revlon in beauty tools.
1

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Elizabeth Arden - The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce website, in the U.S. and internationally, under brands such as Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference and Skin Illuminating in the Elizabeth Arden skin care brands; and Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue and Elizabeth Arden Green Tea in Elizabeth Arden fragrances.
Portfolio - The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as Almay and SinfulColors in color cosmetics; American Crew in men’s grooming products (which are also sold direct-to-consumer on its americancrew.com website); CND in nail polishes, gel nail color and nail enhancements; Cutex nail care products; and Mitchum in anti-perspirant deodorants. The Portfolio segment also includes a multi-cultural hair care line consisting of Creme of Nature hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a hair color line under the Llongueras brand (licensed from a third party) that is sold in the mass retail channel, large volume retailers and other retailers, primarily in Spain.
Fragrances - The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances, as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as: (i) Juicy Couture (which are also sold direct-to-consumer on its juicycouturebeauty.com website), John Varvatos and AllSaints in prestige fragrances; (ii) Britney Spears, Elizabeth Taylor, Christina Aguilera, Jennifer Aniston and Mariah Carey in celebrity fragrances; and (iii) Curve, Giorgio Beverly Hills, Ed Hardy, Charlie, Lucky Brand, ‹PS› (logo of former Paul Sebastian brand), Alfred Sung, Halston, Geoffrey Beene and White Diamonds in mass fragrances.
For certain information regarding the Company's segments' performance, foreign and domestic operations and classes of similar products, refer to Note 17, "Segment Data and Related Information," to the Company’s Audited Consolidated Financial Statements in this Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the "2019 Form 10-K").

2

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Products
The following table sets forth the Company's principal brands that are included in its Revlon, Elizabeth Arden, Portfolio and Fragrances segments by product category:
SegmentCOSMETICSHAIRMEN'S GROOMINGBEAUTY TOOLSFRAGRANCESANTI-PERSPIRANT DEODORANTSSKIN CARE / BODY CARE
OwnedLicensed*
RevlonRevlonRevlon ColorSilkRevlon
Revlon ColorStayRevlon Professional
Elizabeth ArdenElizabeth ArdenElizabeth Arden White TeaVisible Difference
Elizabeth Arden 5th AvenueElizabeth Arden Ceramide
Elizabeth Arden Green TeaElizabeth Arden Pro
Elizabeth Arden Red DoorPrevage
Elizabeth Arden Always RedSkin Illuminating
Eight Hour
SUPERSTART
PortfolioCNDCreme of NatureAmerican CrewMitchumGatineau
AlmayIntercosmod:fi
SinfulColorsOrofluido
CutexLlongueras*
FragrancesCurveJuicy Couture
Giorgio Beverly HillsJohn Varvatos
CharlieAllSaints
HalstonBritney Spears
Jean NatéChristina Aguilera
‹PS›**
Elizabeth Taylor
White DiamondsJennifer Aniston
Mariah Carey
Alfred Sung
Ed Hardy
Lucky Brand
Geoffrey Beene
*Licensed from a third party
** Logo of former Paul Sebastian brand.

The Company operates in four operating segments: Revlon; Elizabeth Arden; Portfolio; and Fragrances, which represent the Company's four reporting segments. For certain information regarding the Company's segments and domestic and foreign operations, refer to Note 17, "Segment Data and Related Information," to the Company’s Audited Consolidated Financial Statements in this 2019 Form 10-K. Further information on the Company's brands by segment appears below.

3

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Revlon Segment:
The Company’s Revlon segment includes cosmetics, hair color and hair care, beauty tools and skin care products sold in approximately 150 countries in the mass retail channel, large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department stores, professional hair and nail salons, one-stop shopping beauty retailers and specialty cosmetics stores in the U.S. and internationally.
Cosmetics - The Company manufactures and markets a broad range of cosmetics, including face, lip, eye and nail products. Certain of the Company’s products incorporate patented, patent-pending or proprietary technology into their production, formulation or design. See "Research and Development" for more information.
Revlon: The Company sells a broad range of cosmetics under its flagship Revlon brand, which are designed to fulfill consumer wants and needs and are principally priced in the upper range for large volume retailers. The Revlon brand is comprised of face makeup, including foundation, powder, blush and concealers; lip makeup, including lipstick, lip gloss and lip liner; eye makeup, including mascaras, eyeliners, eye shadows and brow products; and nail color and nail care lines. Revlon products include innovative formulas and attractive colors that appeal to a wide range of consumers. The following are the key brands within the Revlon segment:
Revlon ColorStay offers consumers a full range of products with long-wearing technology in face, lip, and eye;
Revlon PhotoReady products that are offered in face and eye makeup and are designed with innovative photochromatic pigments that bend and reflect light to give a flawless, airbrushed appearance in any light;
Revlon Age Defying, which consists of face makeup for women in the over-35 age bracket, with ingredients to help reduce the appearance of fine lines and wrinkles;
Revlon Ultra HD, which is a liquid-based lip color offered globally;
Revlon Super Lustrous, which is the Company’s flagship wax-based lip color and is offered in a wide variety of shades of lipstick and lip gloss; and
Revlon Mascara, which consists of a collection of five mascaras, each with a distinct lash benefit including lash definition, length, volume, magnified volume and length and a high impact all-in-one formula.
Hair - The Company sells hair color, hair care and hair treatment products primarily under the Company's Revlon ColorSilk and Revlon Professional franchises.
Revlon ColorSilk hair color and hair care products are sold throughout the world in the mass retail channel to large volume retailers and other retailers and provide radiant, long-lasting color that leaves hair nourished, hydrated and ultra-conditioned.
Revlon Professional includes hair color, hair care and hair treatment products that are distributed exclusively to professional salons, salon professionals and salon distributors and are sold in more than 85 countries. Revlon Professional is synonymous with innovation, fashion and technology to service the most creative salon professionals and their clients. Revlon Professional salon hair color and hair care products include Revlonissimo, Eksperience, Nutri Color Creme, UniqOne and Revlon Professional Equave.
Beauty tools - The Company sells Revlon beauty tools, which include nail, eye and manicure and pedicure grooming tools, eye lash curlers and a full line of makeup brushes under the Revlon brand name.

Elizabeth Arden Segment:
The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce website, in the U.S. and internationally.
The Elizabeth Arden segment is comprised of skin care, color cosmetics and fragrances under the Elizabeth Arden brand, including the following:
Skin Care: Elizabeth Arden sells skin care and color cosmetics products including Visible Difference, Ceramide, SUPERSTART, Prevage, Eight Hour and Skin Illuminating.
4

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Fragrances: The Elizabeth Arden segment produces fragrances including Elizabeth Arden 5th Avenue, Elizabeth Arden White Tea, Elizabeth Arden Red Door and Elizabeth Arden Green Tea.

Portfolio Segment
The Company’s Portfolio segment includes a comprehensive lineup of products sold to hair and nail salons and professional salon distributors, including hair color, shampoos, conditioners, styling products, nail polishes and nail enhancements. The Portfolio segment also includes a multi-cultural line of products sold in both professional salons, large volume retailers and mass retailers.
American Crew and d:fi: The Company sells men’s shampoos, conditioners, gels and other hair care and men's grooming products for use and sale by professional salons under the American Crew brand name. In 2018, the American Crew brand expanded into the prestige channel with the launch of the men's skin and body care line, American Crew Acumen and has introduced the American Crew TechSeries product lineup. American Crew is the "Official Supplier to Men" of quality grooming products that provide the ultimate usage experience and enhance a man’s personal image. American Crew is the leading salon brand created specifically for men and is sold in more than 70 countries (as well as being sold direct-to-consumer on its americancrew.com website). The Company also sells unisex hair products under the d:fi brand, which is a value-priced full line of cleansing, conditioning and styling products.
Almay: The Company’s Almay brand consists of hypo-allergenic, dermatologist-tested, fragrance-free cosmetics and skin care products. The Almay brand is comprised of face makeup, including foundation, pressed powder, primer and concealer; eye makeup, including eye shadows, mascaras and eyeliners; lip makeup; and makeup removers. Key brands within Almay include Almay Smart Shade in face; Almay One Coat in eye; and Almay Color + Care in lip. The Almay brand also has a significant makeup remover business under the core Almay brand name.
SinfulColors: In addition to color cosmetics under SinfulColors, the Company’s SinfulColors brand consists primarily of value-priced nail enamels, available in many bold, vivid and on-trend colors.
Cutex: The Company's Cutex brand consists of a full range of nail care products, including nail polish remover, nail enamels, nail tools and hand and nail care treatments.
CND: The Company sells nail enhancement systems, nail polishes, gel nail color and treatment products and services for use by the professional nail salon industry under the CND brand name. CND-branded professional nail, hand and foot care products are sold in more than 50 countries and the Company recently introduced the CND brand into mass retail through CVS stores. CND nail products include:
CND Shellac brand 14+ day nail color system, which delivers 14+ days of flawless wear, superior color and mirror shine with zero dry-time and no nail damage. The CND Shellac system is a true innovation in chip-free, extended-wear nail color. In 2018, the Company launched CND Shellac Luxe, a 2-step gel polish system that is ready to remove in 60 seconds with no nail damage; and
CND Vinylux weekly polish, a breakthrough nail polish that uses a patent-pending technology and lasts approximately a week. While ordinary polishes become brittle and deteriorate over time, CND Vinylux dries with exposure to natural light to a flawless finish and strengthens its resistance to chips over time.
Mitchum: The Company's Mitchum brand consists of anti-perspirant deodorant products for men and women, with patented ingredients that provide consumers with up to 48 hours of protection.
The Company sells professional hair products under brand names such as Orofluido and Intercosmo, as well as under the premium priced Llongueras brand (licensed from a third party) in Spain. Multi-cultural hair-care products are sold under the Creme of Nature brand, primarily in the U.S., to professional salons, large volume retailers and other retailers.
The Company also sells certain skin care products in the U.S. and internationally under various regional brands, including the Company's Gatineau brand.

5

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Fragrances Segment:

The Company's Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as : (i) Juicy Couture (which are also sold direct-to-consumer on its juicycouturebeauty.com website), John Varvatos and AllSaints in prestige fragrances; (ii) Britney Spears, Elizabeth Taylor, Christina Aguilera, Jennifer Aniston and Mariah Carey in celebrity fragrances; and (iii) Curve, Giorgio Beverly Hills, Ed Hardy, Charlie, Lucky Brand, ‹PS› (logo of former Paul Sebastian brand), Alfred Sung, Halston, Geoffrey Beene and White Diamonds in mass fragrances.
The Company also distributes approximately 100 additional prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers and specialty stores and mass retailers, including mid-tier and chain drug retailers, e-commerce sites and other international and travel retailers.

Marketing
The Company uses various marketing techniques depending on the brand, type of product or target customer, among other variables. For its mass retail products, the Company markets its extensive product lines covering a broad range of price points within large volume retailers and e-commerce sites in the U.S. and within large volume retailers and other retailers internationally. The Company uses social media and other digital marketing, television, outdoor and print advertising and public relations and influencer marketing, as well as point-of-sale merchandising, including displays and samples, coupons and other trial incentives. The Company coordinates its marketing and advertising campaigns for new product launches and innovation with an omni-channel approach. The Company develops, jointly with retailers, customized, tailored point-of-purchase and other focused marketing programs.
The Company also uses cooperative advertising programs, Company-paid or Company-subsidized demonstrators and coordinates in-store promotions and displays. Other marketing strategies, including trial-size products and couponing, are designed to introduce the Company's newest products to consumers and encourage trial and purchase in-store.
For Elizabeth Arden products, the Company’s approach is focused on generating strong retailer and consumer demand across its key brands. The Company emphasizes a competitive marketing mix for each brand and implements plans that are designed to ensure that each brand's positioning is carried through consistently across all consumer touch points. The Company is increasingly leveraging new media, such as social networking and mobile and digital applications, along with traditional consumer reach vehicles, such as television and magazine print advertising, to engage with its consumers through their personally-preferred technologies. Marketing programs for the Company's Elizabeth Arden brands are also integrated with significant cooperative advertising programs that the Company plans and executes with its retailers, often linked with new product innovation and promotions.
For products primarily sold to professional salons and distributors, the Company markets products through educational seminars on such products' application methods and consumer benefits. In addition, the Company uses professional trade advertising, social media and other digital marketing, displays and samples to communicate to professionals and consumers the quality and performance characteristics of its products. In some countries, the Company's direct sales force provides customers with point of sale communication and merchandising for its professional products.
The Company believes that its presence in professional salons benefits the marketing and sale of its products sold through other channels, such as mass retailers or specialty stores, as it enables the Company to improve many of its other product categories, such as hair color, hair care, nail color, nail care and skin care. The presence of regional brands internationally provides the Company with broader brand, geographic coverage and retail diversification beyond large volume retailers, among others.
Additionally, the Company maintains many brand-specific websites, such as www.revlon.com, www.elizabetharden.com, www.almay.com, www.revlonprofessional.com, www.americancrew.com, www.cnd.com and www.mitchum.com, devoted to the Revlon, Elizabeth Arden, Almay, Revlon Professional, American Crew, CND and Mitchum brands, respectively. Each of these websites features product and promotional information for the brands and are updated regularly to stay current with the Company's new product launches and other marketing, advertising and promotional campaigns. The Company sells direct-to-consumer on-line through its elizabetharden.com, americancrew.com and juicycouturebeauty.com websites.

6

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Research and Development
The Company believes that it is an industry leader in the development of innovative and technologically-advanced cosmetics and beauty products. The Company's marketing and research and development groups identify consumer needs and shifts in consumer preferences in order to develop new products, introduce line extensions and promotions and redesign or reformulate existing products to satisfy these needs and preferences. The Company's research and development group is comprised of departments specialized in the technologies critical to many of the Company's product lines. The Company also utilizes specialty laboratories and manufacturers in its supply chain for the development of certain new products, such as fragrances and skin care. The Company continues to refine its rigorous process for the ongoing development and evaluation of new product concepts, led by executives in marketing, sales, research and development, and including input from operations, law and finance. This process has created a comprehensive, long-term portfolio strategy that is intended to optimize the Company's ability to regularly launch innovative new product offerings and to effectively manage the Company’s product portfolio.
The Company operates an extensive research and development facility in Edison, New Jersey for products under brands such as Revlon, Almay and Elizabeth Arden. The Company also has research facilities for its professional products in the U.S. (in California and Florida), Spain and Mexico. The scientists at these various facilities are responsible for performing all of the Company’s research and development activities for new products, ideas, concepts and packaging. The Company’s package development and engineering function is also part of the greater research and development organization and fosters a strong synergy of package and formula development, which is integral to a product’s success. The research and development group performs extensive safety and quality testing on the Company’s products, including toxicology, microbiology, efficacy and package testing. Additionally, quality control testing is performed at each of the Company’s manufacturing facilities.
As of December 31, 2019, the Company employed approximately 200 people in its research and development activities, including specialists in pharmacology, toxicology, chemistry, microbiology, engineering, biology, dermatology and quality control.

Manufacturing and Related Operations and Raw Materials
During 2019, the Company’s products were primarily produced at the Company’s facilities in the U.S. (North Carolina and Florida), South Africa, Spain, Italy and Mexico, and at third-party facilities around the world. A significant portion of Elizabeth Arden products were also produced by third-party suppliers and contract manufacturers in the U.S. and Europe.
The Company continually reviews its manufacturing needs against its manufacturing capacities to identify opportunities to reduce costs and operate more efficiently. The Company purchases raw materials and components throughout the world, and continuously pursues reductions in cost of goods through the global sourcing of raw materials and components from qualified vendors, utilizing its purchasing capacity to optimize cost reductions. The Company’s global sourcing strategy for materials and components from qualified vendors is also designed to ensure that the Company maintains a continuous supply of high-quality raw materials and components. The Company believes that alternate sources of raw materials and components exist and does not anticipate any significant shortages of, or difficulty in obtaining, such materials.
As previously disclosed, the Company's 2018 net sales were negatively impacted by service level disruptions that occurred at the Company's Oxford, N.C. manufacturing facility resulting from the Company's launch of a new SAP enterprise resource planning ("ERP") system. This launch impacted the Company's ability to manufacture certain quantities of finished goods and fulfill shipments to retail customers in the U.S. and internationally and caused the Company to incur substantial costs during 2018 to remediate the decline in customer service levels. As of December 31, 2018, the Oxford, N.C. manufacturing facility had resumed operating at pre-SAP levels and the Company was continuing to re-fill inventories across its retail partners, particularly internationally. (See Item 1A. Risk Factors - "The Company depends on its Oxford, North Carolina facility for production of a substantial portion of its products. Disruptions at this facility and/or at other Company or third-party facilities at which the Company's products are manufactured could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.")

7

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Distribution
The Company's products are sold in approximately 150 countries across six continents. The Company utilizes a dedicated sales force in countries where the Company maintains operations, and also utilizes sales representatives and independent distributors to serve certain territories and retailers. (See Item 1A. Risk Factors - "The Company depends on a limited number of customers for a large portion of its net sales, and the loss of one or more of these customers could reduce the Company's net sales and have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows" and "Competition in the beauty industry could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.")
United States. Net sales in the U.S. accounted for approximately 47% of the Company's 2019 net sales, which were made in multiple channels, including mass and prestige retail, e-commerce sites and specialty cosmetics stores. The Company also sells a broad range of beauty products to U.S. Government military exchanges and commissaries. The Company licenses its Revlon trademark to select manufacturers for complementary beauty-related products and accessories that the Company believes have the potential to extend the Company's brand names and image. As of December 31, 2019, 6 of such licenses were in effect for 18 categories of beauty and fashion-related products and services. Pursuant to such licenses, the Company retains strict control over product design and development, product and service quality, advertising and the use of its trademarks. These licensing arrangements offer opportunities for the Company to generate revenues and cash flow through royalties and renewal fees, some of which are prepaid from time-to-time. During 2018, the Company entered into an agreement to re-acquire from its third-party licensee the rights to use the Elizabeth Arden and Red Door trademarks in connection with operating beauty salons and spas, which rights reverted to the Company in the fourth quarter of 2019.
The Company sells its products through the mass retail channel, prestige retailers, perfumeries, boutiques, department and specialty stores, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and e-commerce business. In 2018, the Company launched direct-to-consumer on-line selling capabilities on its elizabetharden.com and juicycouturebeauty.com websites and in 2019 on its americancrew.com and fleshbeauty.com websites. Retail merchandisers maintain the Company's point-of-sale wall displays intended to ensure that high-selling SKUs are in stock and to ensure the optimal presentation of the Company's products in retailers. Products for use in professional salons are sold primarily through wholesale beauty supply distributors in the U.S.
Outside of the United States. Net sales outside the U.S. accounted for approximately 53% of the Company's 2019 net sales. The three countries outside the U.S. with the highest net sales were China, Australia and the U.K. which together accounted for approximately 14% of the Company's 2019 net sales. The Company distributes its mass retail products, prestige products and fragrances through large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department and specialty stores, one-stop shopping beauty retailers, perfumeries, boutiques, travel retailers and distributors. Products for use in professional hair and nail salons are sold directly to the salons by the Company's direct sales force in countries where it has operations and through wholesale beauty supply distributors in other countries outside the U.S.
At December 31, 2019, the Company actively sold its products through wholly-owned subsidiaries established in approximately 25 countries outside of the U.S., as well as through joint ventures in Asia and the Middle East, and through a large number of independent distributors and licensees elsewhere around the world.

Customers
The Company's principal customers for its mass retail products, prestige products and fragrances include large volume retailers and chain drug stores, including well-known retailers such as Walmart, CVS, Target, Kohl’s, Walgreens, TJ Maxx and Marshalls, department stores such as Macy’s, Dillard’s, Ulta, Belk, Sephora, Bloomingdales and Nordstrom in the U.S.; Shoppers DrugMart in Canada; A.S. Watson & Co. retail chains in Asia Pacific and Europe; Walgreens Boots Alliance in the U.S. and the U.K.; Debenhams and Superdrug Stores in the U.K.; as well as a range of specialty stores, perfumeries and boutiques such as The Perfume Shop, Hudson’s Bay, Shoppers Drug Mart, Myer, Douglas and various international and travel retailers such as Nuance, Heinemann and World Duty Free throughout various international regions, and e-commerce retailers such as Tmall in China.
The Company's principal customers for its professional products include Beauty Systems Group, Salon Centric and Ulta Salon, Cosmetics & Fragrance, as well as individual hair and nail salons and other distributors to professional salons.
As is customary in the industry, none of the Company’s customers are under an obligation to continue purchasing products from the Company in the future.
8

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Walmart and its affiliates worldwide accounted for approximately 15% of the Company's 2019 consolidated net sales. The Company expects that Walmart and a small number of other customers will, in the aggregate, continue to account for a large portion of the Company's net sales. (See Item 1A. Risk Factors - "The Company depends on a limited number of customers for a large portion of its net sales, and the loss of one or more of these customers could reduce the Company's net sales and have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.")

Competition
The Company's cosmetics, fragrance, skin care, hair and beauty care products business categories are highly competitive. The Company competes primarily by:
developing quality products with innovative performance features, shades, finishes, components and packaging;
educating consumers, retail customers and salon professionals about the benefits of the Company’s products;
anticipating and responding to changing consumer, retail customer and salon professional demands in a timely manner, including the timing of new product introductions and line extensions;
offering attractively priced products relative to the product benefits provided;
maintaining favorable brand recognition;
generating competitive margins and inventory turns for its customers by providing relevant products and executing effective pricing, incentive and promotional programs and marketing campaigns, as well as social media and influencer marketing activities;
ensuring product availability through effective planning and replenishment collaboration with the Company's customers;
providing strong and effective advertising, marketing, promotion, social media, influencer and merchandising support;
leveraging e-commerce, social media and mobile commerce initiatives and developing an effective omni-channel strategy to optimize the opportunity for consumers to interact with and purchase the Company's products both on-line and in brick and mortar outlets;
maintaining an effective sales force and distributor network; and
obtaining and retaining sufficient retail display and floor space, optimal in-store positioning and effective presentation of its products on-shelf.
The Company competes in selected product categories against numerous multi-national manufacturers, as well as with expanding private label and store-owned brands, particularly in the mass retail channel. In addition to products sold in large volume retailers, distributors, wholesalers, professional salons and demonstrator-assisted retailers, the Company's products also compete with products sold in prestige and department stores, television shopping, door-to-door, specialty stores, one-stop shopping beauty retailers, e-commerce sites, perfumeries and other distribution outlets. The Company's competitors include, among others, L'Oréal S.A., The Procter & Gamble Company, The Estée Lauder Companies Inc., Coty Inc., Shiseido Co., Johnson & Johnson, Kao Corp., Henkel AG & Co., Unilever PLC/Unilever N.V., Beiersdorf AG, Chanel S.A., L Brands, Inc., AmorePacific Corporation, Johnson & Johnson, LG Household & Healthcare, Natura & Co./Avon Products, Colgate-Palmolive Company, Puig, Mary Kay Inc., Hand & Nail Harmony, Inc., Oriflame Holding AG, Markwins International Corporation, Sephora (a division of LVMH Moët Henessy Louis Vuitton SE), Boots UK Limited, e.l.f. Beauty, Inc. The Company also competes to a growing extent against e-commerce focused micro-beauty brands, such as Glossier, Inc., NYX Cosmetics and Urban Decay Cosmetics (both acquired by L'Oréal), Anastasia Beverly Hills, Sigma Beauty, Benefit Cosmetics LLC (a subsidiary of LVMH), BECCA, Inc, and Too Faced Cosmetics, LLC (both acquired by Estée Lauder). (See Item 1A. Risk Factors - "Competition in the beauty industry could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.")

9

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Patents, Trademarks and Proprietary Technology
The Company considers trademark protection to be very important to its business. The Company’s trademarks are registered in the U.S. and in approximately 150 other countries. The Company’s significant trademarks include: (i) in the Company’s Revlon segment, Revlon, Revlon ColorStay, Revlon ColorSilk, Revlon PhotoReady, Revlon Super Lustrous and Revlon Professional; (ii) in the Company’s Elizabeth Arden segment, Elizabeth Arden, Prevage, Eight Hour, SuperStart, Visible Difference, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue, Elizabeth Arden Always Red, Elizabeth Arden White Tea and Elizabeth Arden Green Tea; (iii) in the Company’s Portfolio segment, Almay, Almay Smart Shade, American Crew, CND, CND Shellac Luxe, CND Vinylux, SinfulColors, Mitchum, Cutex, Intercosmo, Orofluido, Creme of Nature and Gatineau; and (iv) in the Company’s Fragrances segment, owned marks such as Curve, Giorgio Beverly Hills, Charlie, Halston, Jean Naté, ‹PS› (logo of former Paul Sebastian brand), Untold, and White Diamonds, as well as licensed trademarks such as Juicy Couture (which are also sold direct-to-consumer on its juicycouturebeauty.com website), John Varvatos and AllSaints in prestige fragrances; Britney Spears, Elizabeth Taylor, Christina Aguilera, Jennifer Aniston and Mariah Carey in celebrity fragrances; and Ed Hardy, Lucky Brand, Alfred Sung and Geoffrey Beene in mass fragrances. The Company regularly renews its trademark registrations in the ordinary course of business.
The Company utilizes certain proprietary and/or patented technologies in the formulation, packaging and/or manufacture of a number of the Company’s products, including, among others, Revlon Age Defying cosmetics, Almay Smart Shade makeup, Revlon ColorSilk hair color, the Prevage skin care products, Mitchum anti-perspirant deodorants, CND Shellac Luxe nail color systems and CND Vinylux nail polishes. The Company considers its proprietary technology and patent protection to be important to its business.
The Company files patent applications in the ordinary course of business for certain of the Company’s new technologies. In general, utility patents are enforceable for up to 20 years from the patent application filing date, subject to paying periodic maintenance fees. The patents that the Company currently owns expire at various times between 2020 and 2037 and the Company expects to continue to file patent applications for certain of its technologies in the ordinary course of business.

Government Regulation
The Company is subject to regulation by the Federal Trade Commission (the "FTC") and the Food and Drug Administration (the "FDA") in the U.S., as well as various other federal, state, local and foreign regulatory authorities, including those in the European Union (the "EU"), Canada and other countries in which the Company operates. The Company’s Oxford, North Carolina manufacturing facility is registered with the FDA as a drug manufacturing establishment, permitting the manufacture of cosmetics and other beauty-care products that contain over-the-counter drug ingredients, such as sunscreens, anti-perspirant deodorants and anti-dandruff hair-care products. Compliance with federal, state, local and foreign laws and regulations pertaining to the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had, and is not anticipated to have, a material effect on the Company's capital expenditures, earnings or competitive position. Regulations in the U.S., the EU, Canada and in other countries in which the Company operates that are designed to protect consumers or the environment have an increasing influence on the Company's product claims, ingredients and packaging. (See Item 1A. Risk Factors - "The Company's products are subject to federal, state and international regulations that could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.")

Employees
As of December 31, 2019, the Company employed approximately 7,100 people, of which approximately 20% were covered by collective bargaining agreements. The Company's total employee population includes the impacts of integration initiatives in connection with the EA Integration Restructuring Program and the 2018 Optimization Program (as hereinafter described), including the impacts of insourcing efforts. The Company believes that its employee relations are satisfactory.

Available Information
The public may access materials that the Company files with the Securities and Exchange Commission ("SEC"), including, without limitation, its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, on the SEC's website at http://www.sec.gov. The Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements and amendments to those reports are also available free of charge on the Company's Internet website at http://www.revloninc.com as soon as reasonably practicable after such reports are electronically filed with or furnished to the SEC.

10

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Item 1A. Risk Factors

In addition to the other information in this report, investors should consider carefully the following risk factors when evaluating the Company’s business. For definitions of certain capitalized terms used in this Form 10-K referring to the Company's debt facilities, see Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations - Financial Condition, Liquidity and Capital Resources - Long-Term Debt Instruments" of this 2019 Form 10-K.
Revlon is a holding company with no business operations of its own and is dependent on its subsidiaries to pay certain expenses and dividends. In addition, shares of the capital stock of Products Corporation, Revlon's wholly-owned operating subsidiary, are pledged by Revlon to secure its obligations under the 2016 Credit Agreements and the 2019 Term Loan Facility.
Revlon is a holding company with no business operations of its own. Revlon's only material asset is all of the outstanding capital stock of Products Corporation, Revlon's wholly-owned operating subsidiary, through which Revlon conducts its business operations. As such, Revlon's net income has historically consisted predominantly of its equity in the net loss of Products Corporation, which for 2019 and 2018 was $151.2 million and $289.1 million, respectively (in each case excluding $7.9 million and $6.3 million, respectively, in expenses primarily related to Revlon being a public holding company). Revlon is dependent on the earnings and cash flow of, and dividends and distributions from, Products Corporation to pay Revlon’s expenses incidental to being a public holding company and to pay any cash dividend or distribution on its Class A Common Stock in each case that may be authorized by Revlon’s Board of Directors.
Products Corporation may not generate sufficient cash flow to pay dividends or distribute funds to Revlon because, for example, Products Corporation may not generate sufficient cash or net income; state laws may restrict or prohibit Products Corporation from issuing dividends or making distributions unless Products Corporation has sufficient surplus or net profits, which Products Corporation may not have; or because contractual restrictions, including negative covenants contained in Products Corporation’s various debt instruments, may prohibit or limit such dividends or distributions.
The terms of Products Corporation's 2016 Credit Agreements, the indentures governing Products Corporation's 6.25% Senior Notes due 2024 (the "6.25% Senior Notes Indenture" and the "6.25% Senior Notes," respectively) and 5.75% Senior Notes due 2021 (the "5.75% Senior Notes Indenture" and the "5.75% Senior Notes," respectively, and, together with the 6.25% Senior Notes Indenture, the "Senior Notes Indentures" and the "Senior Notes," respectively) and the 2019 Term Loan Facility (as hereinafter defined) generally restrict Products Corporation from paying dividends or making distributions to Revlon, except in limited circumstances. For example, Products Corporation is permitted to pay dividends and make distributions to Revlon to enable Revlon to, among other things, maintain its existence and its ownership of Products Corporation, such as paying professional fees (e.g., legal, accounting and insurance fees), regulatory fees (e.g., SEC filing fees and NYSE listing fees), pay certain taxes and other expenses related to being a public holding company and, subject to certain limitations, to pay dividends, if any, on Revlon’s outstanding securities or make distributions in certain circumstances to finance Revlon’s purchase of shares of its Class A Common Stock issued in connection with the delivery of such shares to grantees under the Fourth Amended and Restated Revlon, Inc. Stock Plan, as amended. These limitations therefore restrict Revlon's ability to pay dividends on its Class A Common Stock.
All of the shares of Products Corporation’s capital stock held by Revlon are pledged to secure Revlon’s guarantee of Products Corporation's obligations under its 2016 Credit Agreements and the 2019 Term Loan Facility. A foreclosure upon the shares of Products Corporation's common stock would result in Revlon no longer holding its only material asset, would have a material adverse effect on the holders and price of Revlon’s Class A Common Stock and would be a change of control under Products Corporation’s other debt instruments. (See also Item 1A. Risk Factors - "Shares of Revlon Class A Common Stock and Products Corporation's capital stock are pledged to secure various of Revlon's and/or other of the Company's affiliates’ obligations and foreclosure upon these shares or dispositions of shares could result in the acceleration of debt under Products Corporation's 2016 Senior Credit Facilities, 2018 Foreign Asset-Based Term Facility, 2019 Term Loan Facility, Amended 2019 Senior Line of Credit Facility and/or its Senior Notes and could have other consequences.")
11

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Products Corporation’s substantial indebtedness could adversely affect the Company’s operations and flexibility and Products Corporation’s ability to service its debt.
Products Corporation has a substantial amount of outstanding indebtedness. As of December 31, 2019 the Company’s total indebtedness was $3,252.8 million (or $3,196.4 million net of discounts and debt issuance costs), including: (i) $450.0 million in aggregate principal amount of its 6.25% Senior Notes; (ii) $500.0 million in aggregate principal amount of its 5.75% Senior Notes; (iii) $230.9 million of secured indebtedness under Tranche A of its Amended 2016 Revolving Credit Facility; (iv) $41.5 million of secured indebtedness under Tranche B of its Amended 2016 Revolving Credit Facility; (v) $1,741.5 million in aggregate principal amount of secured indebtedness under its 2016 Term Loan Facility; (vi) $86.3 million in aggregate principal amount of secured indebtedness under its 2018 Foreign Asset-Based Term Facility (as hereinafter defined); (vii) $200.0 million in aggregate principal amount of secured indebtedness under its 2019 Term Loan Facility; (viii) nil in aggregate principal amount of indebtedness under its Amended 2019 Senior Line of Credit Facility (as hereinafter defined); and (ix) $2.6 million in aggregate principal amount of other indebtedness. In addition, as of such date Products Corporation would have had the ability to incur an additional $157.7 million of secured indebtedness under its Amended 2016 Revolving Credit Facility and $30.0 million in aggregate principal amount of indebtedness under its Amended 2019 Senior Line of Credit Facility. If the Company is unable to maintain or increase its profitability and cash flow and sustain such results in future periods, it could adversely affect the Company's operations and Products Corporation's ability to service its debt and/or comply with the financial and/or operating covenants under its various debt instruments. (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply.")
The Company is subject to the risks normally associated with substantial indebtedness, including the risk that the Company’s profitability and cash flow will be insufficient to meet required payments of principal and interest under Products Corporation’s various debt instruments, and the risk that Products Corporation will be unable to refinance existing indebtedness when it becomes due or, if it is unable to comply with the financial or operating covenants under its various debt instruments, to obtain any necessary consents, waivers or amendments or that the terms of any such refinancing and/or consents, waivers or amendments will be less favorable than the current terms of such indebtedness. Products Corporation’s substantial indebtedness could also have the effect of:
limiting the Company’s ability to fund (including by obtaining additional financing) the costs and expenses of executing the Company’s business initiatives, future working capital, capital expenditures, advertising, promotional and/or marketing expenses, new product development costs, purchases and reconfigurations of wall displays, acquisitions, and related integration costs, investments, restructuring programs and other general corporate purposes;
requiring the Company to dedicate a substantial portion of its cash flow from operations to payments on Products Corporation’s indebtedness, thereby reducing the availability of the Company’s cash flow necessary for executing the Company’s business initiatives and for other general corporate purposes;
placing the Company at a competitive disadvantage compared to its competitors that have less debt;
exposing the Company to potential events of default (if not cured or waived) under the financial and operating covenants contained in Products Corporation’s various debt instruments;
limiting the Company’s flexibility in responding to changes in its business and the industry in which it operates; and
making the Company more vulnerable in the event of adverse economic conditions or a downturn in its business.
Although agreements governing Products Corporation’s indebtedness, including the 2016 Credit Agreements, the Senior Notes Indentures and the 2019 Term Loan Agreement (as hereinafter defined), limit Products Corporation’s ability to borrow funds, under certain circumstances Products Corporation is allowed to borrow a significant amount of additional money, some of which, in certain circumstances and subject to certain limitations, could be secured indebtedness. To the extent that more debt, whether secured or unsecured, is added to the Company's current debt levels, the risks described above would increase further. See “Recent Developments – 2020 Refinancing Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
12

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Products Corporation’s ability to pay the principal amount of its indebtedness depends on many factors.
Tranche B under the Amended 2016 Revolving Credit Facility matures no later than April 2020; the Amended 2019 Senior Line of Credit Facility matures on December 31, 2020; the 5.75% Senior Notes mature in February 2021; the 2018 Foreign Asset-Based Term Facility matures in July 2021; Tranche A under the Amended 2016 Revolving Credit Facility matures no later than September 2021; the 2019 Term Loan Facility matures no later than August 2023; the 2016 Term Loan Facility matures no later than September 2023; and the 6.25% Senior Notes mature in August 2024. Also, while the 2019 Term Loan Facility is scheduled to mature no later than August 2023, its maturity would accelerate to the earliest of: (y) the 180th day prior to the maturity of Products Corporation’s existing 2016 Term Loan Facility, if any loans under the 2016 Term Loan Facility remain outstanding and have not been replaced or refinanced by such date; and (z) the date of any springing maturity of the 2016 Term Loan Facility (i.e., the 91st day prior to the maturity of the 5.75% Senior Notes due February 15, 2021 if any 5.75% Senior Notes remain outstanding by such date). Tranche A of the Amended 2016 Revolving Credit Facility has a springing maturity similar to the 2016 Term Loan Facility. For a more complete description of the maturities of these debt instruments, including events that could accelerate their respective maturities, see Note 9, “Debt” to the Company's Audited Consolidated Financial Statements in this 2019 Form 10-K. See also, “Recent Developments – 2020 Refinancing Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Products Corporation currently anticipates that, in order to pay the principal amount of its outstanding indebtedness upon the occurrence of any event of default, or to repurchase any of the Senior Notes if a change of control occurs, or in the event that Products Corporation’s cash flows from operations are insufficient to allow it to pay the principal amount of its indebtedness by their respective maturity dates, the Company will be required to refinance some or all of Products Corporation’s indebtedness, seek to sell assets or operations, seek to sell additional Revlon equity, seek to sell debt securities of Revlon or Products Corporation and/or seek additional capital contributions or loans from MacAndrews & Forbes or from the Company’s other affiliates and/or third parties. The Company may be unable to take any of these actions due to a variety of commercial or market factors or constraints in Products Corporation’s various debt instruments, including, for example, market conditions being unfavorable for an equity or debt issuance, additional capital contributions or loans not being available from affiliates and/or third parties, or that the transactions may not be permitted under the terms of Products Corporation’s various debt instruments then in effect, including restrictions on the incurrence of additional debt, incurrence of liens, asset dispositions and/or related party transactions included in such debt instruments. Such actions, if ever taken, may not enable the Company to satisfy its cash requirements if the actions do not result in sufficient cost reductions or generate a sufficient amount of additional capital, as the case may be.
None of the Company’s affiliates are required to make any capital contributions, loans or other payments to Products Corporation regarding its obligations on its indebtedness, other than the Amended 2019 Senior Line of Credit Facility. Products Corporation may not be able to pay the principal amount of its indebtedness using any of the above actions because, under certain circumstances, the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the 2019 Term Loan Agreement, the Senior Notes Indentures, any of Products Corporation's other debt instruments and/or the debt instruments of Products Corporation’s subsidiaries then in effect may not permit the Company to take such actions. (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply").
The future state of the credit markets, including any volatility and/or tightening of the credit markets and reduction in credit availability, could adversely impact the Company’s ability to refinance or replace, in whole or in part, Products Corporation’s outstanding indebtedness by their respective maturity dates, which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.
Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply.
The agreements that govern Products Corporation's indebtedness, including the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the 2019 Term Loan Agreement and Products Corporation's Senior Notes Indentures, contain a number of significant restrictions and covenants that limit Products Corporation’s ability (subject in each case to certain exceptions) to, among other things:
borrow money;
use assets as security in other borrowings or transactions;
pay dividends on stock or purchase stock;
sell assets and use the proceeds from such sales;
enter into certain transactions with affiliates;
make certain investments;
13

Table of Contents

REVLON, INC. AND SUBSIDIARIES
prepay, redeem or repurchase specified indebtedness; and
permit restrictions on the payment of dividends to Products Corporation by its subsidiaries.
These covenants affect Products Corporation’s operating flexibility by, among other things, restricting its ability to incur indebtedness that could be used to fund the costs of executing the Company’s business initiatives and to grow the Company’s business, as well as to fund general corporate purposes.
Certain breaches under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the 2019 Term Loan Agreement, the Amended 2019 Senior Line of Credit Agreement and/or the Senior Notes Indentures would permit the Company’s lenders to accelerate amounts outstanding thereunder. The acceleration of amounts outstanding under the 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility, the 2019 Term Loan Facility, the Amended 2019 Senior Line of Credit Facility and/or the Senior Notes would in certain circumstances constitute an event of default under the other instruments permitting amounts outstanding under such instruments to be accelerated. See “Recent Developments – 2020 Refinancing Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.” In addition, holders of the Senior Notes may require Products Corporation to repurchase their notes in the event of a change of control under the applicable indenture and a change of control would be an event of default under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement and the 2019 Term Loan Agreement. Products Corporation may not have sufficient funds at the time of any such breach or change of control to repay, in full or in part, amounts outstanding under the 2016 Senior Credit Facilities, the 2019 Term Loan Facility, the Amended 2019 Senior Line of Credit Facility or the 2018 Asset-Based Term Facility or to repay, repurchase or redeem, in full or in part, the Senior Notes.
Events beyond the Company’s control could impair the Company’s operating performance, which could affect Products Corporation’s ability to comply with the terms of Products Corporation’s debt instruments. Such events may include decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company’s competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise; changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to any further consumption declines that the Company has experienced; inventory management by the Company's customers; inventory de-stocking by certain retail customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; less than anticipated results from the Company's existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company’s expenses, including, without limitation, those for pension expense under its benefit plans, restructuring programs and related severance expenses, acquisitions and related integration costs, capital expenditures, costs related to litigation, advertising, promotional and/or marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the Company's anticipated level of expenses.
Under such circumstances, Products Corporation may be unable to comply with the requirements of one or more of its various debt instruments, including any financial covenants in the 2016 Credit Agreements and the 2019 Term Loan Agreement. If Products Corporation is unable to satisfy such requirements at any future time, Products Corporation would need to seek an amendment or waiver of such requirements. The respective lenders under the 2016 Credit Agreements and/or the 2019 Term Loan Agreement may not consent to any amendment or waiver requests that Products Corporation may make in the future, and, if they do consent, they may only do so on terms that are unfavorable to Products Corporation and/or Revlon.

If Products Corporation is unable to obtain any such waiver or amendment, Products Corporation's inability to meet the requirements of the 2016 Credit Agreements and/or the 2019 Term Loan Agreement would constitute an event of default under such agreements, which, under certain circumstances, would permit the bank lenders to accelerate the repayment of the 2016 Senior Credit Facilities and the 2019 Term Loan Facility, and, under certain circumstances, would constitute an event of default under the 2018 Foreign Asset-Based Term Agreement, the Amended 2019 Senior Line of Credit Agreement and the Senior Notes Indentures. An event of default under the Senior Notes Indentures would permit the respective Notes Trustee or the Requisite Note Holders to accelerate payment of the principal and accrued, but unpaid, interest on the respective Senior Notes. An event of default under the Amended 2019 Senior Line of Credit Agreement, under certain circumstances, would permit the lenders to accelerate the repayment of such facility.

14

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Products Corporation’s assets and/or cash flows and/or that of Products Corporation’s subsidiaries may not be sufficient to fully repay borrowings under its various debt instruments, either upon maturity or if accelerated upon an event of default or change of control, and if the Company is required to repay, repurchase and/or redeem, in whole or in part, amounts outstanding under its 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility, 2019 Term Loan Facility, Amended 2019 Senior Line of Credit Facility and/or its Senior Notes, it may be unable to refinance or restructure the payments on such debt. See “Recent Developments – 2020 Refinancing Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Further, if the Company is unable to repay, refinance or restructure its indebtedness under the 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility and/or the 2019 Term Loan Facility, the lenders could proceed against the collateral securing that indebtedness, subject to certain conditions and limitations as set forth in the related intercreditor agreements and collateral agreements. As described above, the consequences of complying with the foregoing restrictions, covenants and limitations under the Company’s various debt instruments could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.
Limits on Products Corporation's borrowing capacity under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility may affect the Company's ability to finance its operations.
At December 31, 2019, Products Corporation had $272.4 million in aggregate borrowings outstanding under the Amended 2016 Revolving Credit Facility and $86.3 million outstanding under the 2018 Foreign Asset-Based Term Facility. While the Amended 2016 Revolving Credit Facility provides for up to $441.5 million of commitments, the Company’s ability to borrow funds under such facility is limited by a borrowing base determined relative to the value, from time-to-time, of certain eligible assets.
While the 2018 Foreign Asset-Based Term Facility provides for a euro-denominated senior secured asset-based term loan facility in an aggregate principal amount of €77 million, the full amount of which was funded on the closing of the facility in July 2018, the 2018 Foreign Asset-Based Term Agreement requires the maintenance of a borrowing base supporting the borrowing thereunder, based on the sum of: (i) 85% of eligible accounts receivable; and (ii) 90% of the net orderly liquidation value of eligible inventory, in each case with respect to certain of Products Corporation’s subsidiaries organized in Australia, Bermuda, Germany, Italy, Spain and Switzerland, subject to certain customary availability reserves.
Under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility, if the value of the Company's eligible assets is not sufficient to support the full borrowing base under the respective facility, Products Corporation will not have complete access to the entire commitment available under such facilities, but rather would have access to a lesser amount as determined by the borrowing base.
The Borrowers must prepay loans under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility to the extent that outstanding loans exceed its respective borrowing base Under the 2018 Foreign Asset-Based Term Facility, in lieu of a mandatory prepayment, the Loan Parties may deposit cash in an amount not to exceed 10% of the borrowing base into a designated U.S. bank account with the Agent that is subject to a control agreement (such cash, the "Qualified Cash"). If any such over-advance has not been cured within 60 days, the Qualified Cash may be applied, at the Agent’s option, to prepay the loans under the 2018 Foreign Asset-Based Term Facility. To the extent certain levels of availability are obtained during a certain period of time, the Borrowers can withdraw the Qualified Cash from such bank account. In addition, the 2018 Foreign Asset-Based Term Facility is subject to mandatory prepayments from the net proceeds from the incurrence by the Loan Parties of debt not permitted thereunder.
As Products Corporation continues to manage its working capital (including its and its subsidiaries inventory and accounts receivable, which are significant components of the eligible assets comprising the borrowing base under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility), this could reduce the borrowing base under the Amended 2016 Revolving Credit Facility and/or the 2018 Asset-Based Term Facility. Further, if Products Corporation borrows funds under the Amended 2016 Revolving Credit Facility, subsequent changes in the value or eligibility of the assets within the borrowing base could require Products Corporation to pay down amounts outstanding under such facility so that there is no amount outstanding in excess of the then-existing borrowing base. Likewise, subsequent changes in the value or eligibility of the assets within the borrowing base under the 2018 Foreign Asset-Based Term Facility could require Products Corporation to pay down amounts outstanding under such facility so that there is no amount outstanding in excess of the then-existing borrowing base, which, unlike the Amended 2016 Revolving Credit Facility, cannot be re-borrowed.
The Company’s ability to borrow under the Amended 2016 Revolving Credit Facility is also conditioned upon its compliance with other covenants in the agreements that govern the 2016 Senior Credit Facilities. Because of these limitations, the Company may not always be able to meet its cash requirements with funds borrowed under the Amended 2016 Revolving Credit Facility, which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.
15

Table of Contents

REVLON, INC. AND SUBSIDIARIES
If one or more lenders under the Amended 2016 Revolving Credit Facility are unable to fulfill their commitment to advance funds to Products Corporation under such facility, it would impact the Company’s liquidity and, depending upon the amount involved and the Company’s liquidity requirements, it could have an adverse effect on the Company’s ability to fund its operations, which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.
At December 31, 2019, the Company had a liquidity position of $278.7 million, consisting of: (i) $104.3 million of unrestricted cash and cash equivalents; (ii) $157.7 million in available borrowing capacity under Products Corporation's Amended 2016 Revolving Credit Facility (which had $272.4 million drawn at such date); (iii) $30 million in available borrowing capacity under the Amended 2019 Senior Line of Credit Facility, which had no borrowings at such date; and less (iv) $13.3 million of outstanding checks. See “Recent Developments – 2020 Refinancing Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
A substantial portion of Products Corporation's indebtedness is subject to floating interest rates and the potential discontinuation or replacement of LIBOR could result in an increase to our interest expense.
A substantial portion of the Products Corporation's indebtedness is subject to floating interest rates, which makes the Company more vulnerable in the event of adverse economic conditions, increases in prevailing interest rates or a downturn in the Company’s business. As of December 31, 2019, $2,253.6 million of Products Corporation’s total indebtedness, or approximately 71% of its total indebtedness, was subject to floating interest rates.
In July 2017, the U.K.’s Financial Conduct Authority, which regulates LIBOR, announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021. It is unclear whether or not LIBOR will cease to exist at that time (and if so, what reference rate will replace it) or if new methods of calculating LIBOR will be established such that it continues to exist after 2021. Certain of Products Corporation’s financing agreements, including its 2016 Term Loan Facility, the Amended 2016 Revolving Credit Facility and the 2019 Term Loan Facility are made at variable rates that use LIBOR as a benchmark for establishing the applicable interest rate. While the 2016 Credit Agreements contain limited “fallback” provisions providing for comparable or successor rates in the event LIBOR is unavailable, these provisions may not adequately address the actual changes to LIBOR or its successor rates. For example, if future rates based upon the successor reference rate (or a new method of calculating LIBOR) are higher than LIBOR rates as currently determined, it may have a material adverse effect on our business, prospects, results of operations, financial condition and/or cash flows. On the other hand, if future rates based upon the successor reference rate (or a new method of calculating LIBOR) are lower than LIBOR rates as currently determined, the lenders under such credit agreements may seek amendments to increase the applicable interest rate margins or invoke their right to require the use of the alternate base rate in place of LIBOR, which could result in an increase to our interest expense as discussed below. By contrast, the 2019 Term Loan Facility does not have provisions for selecting or requiring the alternative base rate, and therefore in the event that LIBOR is discontinued in the future and a comparable or successor rate is not approved by the required lenders under the 2019 Term Loan Facility, it may become necessary to amend the 2019 Term Loan Facility. More generally, a phase-out of LIBOR could cause market volatility or disruption and may adversely affect our access to the capital markets and cost of funding, which would have a material adverse effect on our business, prospects, results of operations, financial condition and/or cash flows.
Similar considerations as the ones described above with respect to LIBOR as benchmark for establishing interest rates apply to EURIBOR. Our 2018 Foreign Asset-Based Term Facility is denominated in Euros and the interest rate thereunder is tied to EURIBOR. To the extent that EURIBOR becomes unavailable, the agreement contains fallback provisions ultimately providing for a rate determined by the administrative agent as the all-in-cost of funds for borrowings denominated in Euros with maturities comparable to the interest period applicable to the loans under the 2018 Foreign Asset-Based Term Facility.
16

Table of Contents

REVLON, INC. AND SUBSIDIARIES
As of December 31, 2019, the entire $1,741.5 million in aggregate principal amount outstanding under the 2016 Term Loan Facility bore interest, at Product Corporation’s option, at a rate per annum of LIBOR (which has a floor of 0.75%) plus a margin of 3.5% or an alternate base rate plus a margin of 2.5%, payable quarterly, at a minimum. At December 31, 2019, LIBOR and the alternate base rate for the 2016 Term Loan Facility were 4.75% and 1.908%, respectively. As of December 31, 2019, $230.9 million in aggregate principal amount outstanding under Tranche A of the Amended 2016 Revolving Credit Facility bore interest, at Products Corporation’s option, at a rate per annum equal to either: (i) the alternate base rate plus an applicable margin equal to 0.25%, 0.50% or 0.75%, depending on the average excess availability (based on the borrowing base as most recently reported by Products Corporation to the administrative agent from time-to-time); or (ii) the Eurocurrency rate plus an applicable margin equal to 1.25%, 1.5% or 1.75%, depending on the average excess availability (based on the borrowing base as most recently reported by Products Corporation to the administrative agent from time-to-time). As of December 31, 2019, $41.5 million in aggregate principal amount outstanding under Tranche B of the Amended 2016 Revolving Credit Facility bore interest, at Products Corporation’s option, at a rate per annum equal to either: (i) the alternate base rate plus an applicable margin equal to 1.5%, 1.75% or 2.0%, depending on the average excess availability (based on the borrowing base as most recently reported by Products Corporation to the administrative agent from time-to-time); or (ii) the Eurocurrency rate plus an applicable margin equal to 2.5%, 2.75% or 3.0%, depending on the average excess availability (based on the borrowing base as most recently reported by Products Corporation to the administrative agent from time-to-time). Under Tranches A and B of the Amended 2016 Revolving Credit Facility, the applicable margin increases as average excess availability thereunder decreases. Under the 2018 Foreign Asset-Based Term Facility, which had $86.3 million in aggregate principal amount outstanding as of December 31, 2019, interest accrues on borrowings at a rate per annum equal to the EURIBOR rate plus a 6.50% applicable margin. Interest accrues on the 2019 Term Loan Facility, which had $200.0 million in aggregate principal amount outstanding as of December 31, 2019, at a rate per annum of one-month adjusted LIBOR (which has a floor of 0%), plus a margin of 9.50%.
If any of LIBOR (or its successor rate), the prime rate or the federal funds effective rate increases, Products Corporation’s debt service costs will increase to the extent that Products Corporation has elected such rates for its outstanding loans. Based on the amounts outstanding under the 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility, the 2019 Term Loan Facility and other short-term borrowings (which, in the aggregate, are Products Corporation’s only debt currently subject to floating interest rates) as of December 31, 2019, a 1% increase in LIBOR (or an equivalent successor rate) would increase the Company’s annual interest expense by $21.4 million. Based on the same amounts outstanding, a change from LIBOR to the alternate base rate in the case of the 2016 Credit Agreements would increase the Company’s annual interest expense by $37.7 million. Increased debt service costs would adversely affect the Company’s cash flows and could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.
The Company's ability to service its debt and meet its cash requirements depends on many factors, including achieving anticipated levels of revenue and expenses. If such revenue or expense levels prove to be other than as anticipated, the Company may be unable to meet its cash requirements or Products Corporation may be unable to meet the requirements of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement, 2019 Term Loan Agreement and/or Amended 2019 Senior Line of Credit Agreement, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company currently expects that operating revenues, cash on hand, and funds that may be available for borrowing under the Amended 2016 Revolving Credit Facility, the Amended 2019 Senior Line of Credit Facility, the 2020 Refinancing Transactions and other permissible borrowings will be sufficient to enable the Company to cover its operating expenses for 2020, including: cash requirements for the payment of expenses in connection with executing the Company's business initiatives and its advertising, promotional, pricing and/or marketing plans; purchases of permanent wall displays; capital expenditure requirements; debt service payments and costs; cash tax payments; pension and other post-retirement plan contributions; payments in connection with the Company's restructuring programs (including, without limitation, the EA Integration Restructuring Program, the 2018 Optimization Program and the Revlon 2020 Restructuring Program); severance not otherwise included in the Company's restructuring programs; business and/or brand acquisitions (including, without limitation, through licensing transactions), if any; debt and/or equity repurchases, if any; costs related to litigation; and payments in connection with discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade. See “Recent Developments – 2020 Refinancing Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
17

Table of Contents

REVLON, INC. AND SUBSIDIARIES
However, if the Company's anticipated level of revenue is not achieved because of, for example, decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company's competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise; changes in consumer purchasing habits, including with respect to retailer preferences and/or sales channels, such as due to the consumption declines in core beauty categories in the mass retail channel in North America, which continues to have a negative impact on net sales of Revlon color cosmetics and SinfulColors color cosmetics; inventory management by the Company's customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; less than anticipated results from the Company's existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company's expenses, including, without limitation, those for pension expense under its benefit plans, capital expenditures, restructuring and severance costs (including, without limitation, for the EA Integration Restructuring Program, the 2018 Optimization Program and the Revlon 2020 Restructuring Program), acquisition and integration costs, costs related to litigation, advertising, promotional or marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the anticipated level of expenses, the Company's current sources of funds may be insufficient to meet its cash requirements. In addition, such developments, if significant, could reduce the Company's revenues and could have a material adverse effect on Products Corporation's ability to comply with the terms of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement, 2019 Term Loan Agreement and/or Amended 2019 Senior Line of Credit Agreement (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply," which discusses, among other things, the consequences of noncompliance with Products Corporation's debt covenants).
If the Company's operating revenues, cash on hand and/or funds that may be available for borrowing are insufficient to cover the Company's expenses and/or are insufficient to enable Products Corporation to comply with the requirements of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement, 2019 Term Loan Agreement and/or Amended 2019 Senior Line of Credit Agreement, the Company could be required to adopt one or more of the alternatives listed below:
delaying the implementation of or revising certain aspects of the Company's business initiatives;
reducing or delaying purchases of wall displays and/or expenses related to the Company's advertising, promotional and/or marketing activities;
reducing or delaying capital spending;
implementing new restructuring programs;
refinancing Products Corporation's indebtedness;
selling assets or operations;
seeking additional capital contributions and/or loans from MacAndrews & Forbes, the Company's other affiliates and/or third parties;
selling additional Revlon equity or debt securities or Products Corporation's debt securities; and/or
reducing other discretionary spending.
The Company may not be able to take any of these actions because of a variety of commercial or market factors or constraints in one or more of Products Corporation's various debt instruments, including, for example, market conditions being unfavorable for an equity or a debt issuance, additional capital contributions or loans not being available from affiliates and/or third parties, or that the transactions may not be permitted under the terms of one or more of Products Corporation's various debt instruments then in effect, such as due to restrictions on the incurrence of debt, incurrence of liens, asset dispositions and/or related party transactions. If the Company is required to take any of these actions, it could have a material adverse effect on its business, prospects, results of operations, financial condition and/or cash flows.
Such actions, if ever taken, may not enable the Company to satisfy its cash requirements or enable Products Corporation to comply with the terms of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement and/or 2019 Term Loan Agreement if the actions do not result in sufficient cost reductions or generate a sufficient amount of additional capital, as the case may be. (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply," which discusses, among other things, the consequences of noncompliance with Products Corporation's debt covenants).

18

Table of Contents

REVLON, INC. AND SUBSIDIARIES
If the Company is unable to consummate its committed financing, or otherwise obtain sufficient alternative funding, for the repayment in full of its 5.75% Senior Notes due 2021, certain of its credit facilities will be subject to an Accelerated Maturity Event which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.

The 5.75% Senior Notes are due on February 15, 2021. If Products Corporation is unable to repay or refinance the 5.75% Senior Notes in full prior to November 16, 2020 (91 days before they are due) (the "Accelerated Maturity Date"), then, subject to certain minimum liquidity-related exceptions, the 2016 Term Loan Facility, Tranche A of the Amended 2016 Revolving Credit Facility and the 2019 Term Loan Facility will become due on the Accelerated Maturity Date (an "Accelerated Maturity Event"). As of December 31, 2019, the aggregate principal amount of indebtedness outstanding under the 5.75% Senior Notes, the 2016 Term Loan Facility, Tranche A of the Amended 2016 Revolving Credit Facility and the 2019 Term Loan Facility was $500.0 million, $1,741.5 million, $230.9 million, and $200.0 million, respectively.

On March 9, 2020, Products Corporation entered into a commitment letter (the “2020 Commitment Letter”) with Jefferies Finance LLC to provide sufficient financing to refinance the 5.75% Senior Notes and the 2019 Term Loan Facility in full prior to the Accelerated Maturity Date. The financing under the 2020 Commitment Letter is available until June 30, 2020 and is subject to customary conditions precedent, such as the execution of definitive loan and security documents, absence of material adverse change and other customary conditions. Although the Company expects that it will be able to satisfy the conditions to the financing contemplated by the 2020 Commitment Letter, if the financing does not occur for any reason, the Company will need to obtain sufficient alternative funding (whether from borrowed funds or from the proceeds of asset sales) or amend or obtain a waiver from the lenders under the 2016 Term Loan Facility, Tranche A of the Amended 2016 Revolving Credit Facility and the 2019 Term Loan Facility. There can be no assurance that the Company will be able to obtain any such alternative financing or amendment or waiver on favorable terms or at all. If an Accelerated Maturity Event were to occur, it could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows. For a discussion of factors affecting Products Corporation's ability to repay or refinance indebtedness by maturity and the consequences of its inability to do so, see Item 1A. Risk Factors – “Products Corporation’s ability to pay the principal amount of its indebtedness depends on many factors.”

The Company depends on its Oxford, North Carolina facility for production of a substantial portion of its products. Disruptions at this facility and/or at other Company or third-party facilities at which the Company's products are manufactured could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company produces a substantial portion of its products at its Oxford, North Carolina facility. Significant unscheduled downtime at this facility, or at other Company facilities and/or third-party facilities at which the Company's products are manufactured, whether due to equipment breakdowns, power failures, natural disasters, weather conditions hampering delivery schedules, shortages of raw materials, technology disruptions or other disruptions, including those caused by transitioning manufacturing across these facilities, or any other cause could have a material adverse effect on the Company's ability to provide products to its customers, which could have a material adverse effect on the Company's sales, business, prospects, results of operations, financial condition and/or cash flows. Additionally, if product sales exceed the Company's forecasts, internal or third-party production capacities and/or the Company's ability to procure sufficient levels of finished goods, raw materials and/or components from third-party suppliers, the Company could, from time-to-time, not have an adequate supply of products to meet customer demands, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
19

Table of Contents

REVLON, INC. AND SUBSIDIARIES
Volatility in costs and disruption in the supply of materials and services could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company purchases raw materials, including essential oils, alcohols, chemicals, containers and packaging components, from various third-party suppliers. Substantial cost increases and the unavailability of raw materials or other commodities, as well as higher costs for energy, transportation and other necessary services have adversely affected and may continue to adversely affect the Company’s profit margins if it is unable to wholly or partially offset them, such as by achieving cost efficiencies in its supply chain, manufacturing and/or distribution activities. In addition, the Company purchases certain finished goods, raw materials, packaging and other components from single-source suppliers or a limited number of suppliers and if the Company is required to find alternative sources of supply, these new suppliers may have to be qualified under applicable industry, governmental and Company-mandated vendor standards, which can require additional investment and be time-consuming. Any significant disruption to the Company’s manufacturing or sourcing of products or raw materials, packaging and other components for any reason could interrupt and delay the Company’s supply of products to its retail customers. Also, the Company is continually looking for opportunities to provide essential business services in a more cost-effective manner.  In some cases, the Company outsources certain functions that it believes can be performed more efficiently by third parties, such as in the areas of IT, finance, tax and human resources. These third parties could fail to provide the expected level of services, provide them on a timely basis or to provide them at the expected fees. Such events, if not promptly remedied, could have a material adverse effect on the Company’s business, prospects, results of operation, financial condition and/or cash flows.

The Company's financial performance depends on its ability to anticipate and respond to consumer trends and changes in consumer preferences. New product introductions may not be as successful as the Company anticipates, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company has a rigorous process for the continuous development and evaluation of new product concepts, led by executives in marketing, sales, research and development, product development, operations, law and finance. However, consumer preference and spending patterns change rapidly and cannot be predicted with certainty. There can be no assurance that the Company will anticipate and respond to trends for beauty products effectively. Each new product launch, including those resulting from the Company's recently updated product development process, carries risks, as well as the possibility of unexpected consequences, including:
the acceptance of the Company's new product launches by, and sales of such new products to, the Company's customers may not be as high as the Company anticipates;
the Company's marketing, promotional, advertising and/or pricing strategies for its new products may be less effective than planned and may fail to effectively reach the targeted consumer base or engender the desired consumption of the Company's products by consumers;
the rate of purchases by the Company's consumers may not be as high as the Company anticipates;
the Company's wall displays to showcase its new products may fail to achieve their intended effects;
the Company may experience out-of-stocks and/or product returns exceeding its expectations as a result of the Company's new product launches or space reconfigurations or as a result of reductions in retail display space by the Company's customers;
the Company's net sales may also be impacted by inventory management by its customers or changes in pricing, marketing, advertising and/or promotional strategies by its customers;
the Company may incur costs exceeding its expectations as a result of the continued development and launch of new products, including, for example, unanticipated levels of research and development costs, advertising, promotional and/or marketing expenses, sales return expenses or other costs related to launching new products;
the Company may experience a decrease in sales of certain of the Company's existing products as a result of newly-launched products, the impact of which could be exacerbated by shelf space limitations and/or any shelf space loss. (See also Item 1A. Risk Factors - "Competition in the beauty industry could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.").
the Company's product pricing strategies for new product launches may not be accepted by its customers and/or its consumers, which may result in the Company's sales being less than it anticipates;
the Company may experience a decrease in sales of certain of the Company's products as a result of counterfeit products and/or products sold outside of their intended territories; and/or
20

Table of Contents

REVLON, INC. AND SUBSIDIARIES
delays or difficulties impacting the Company's ability, or the ability of the Company's suppliers, to timely manufacture, distribute and ship products or raw materials, as the case may be, displays or display walls in connection with launching new products, such as due to inclement weather conditions or other delays or difficulties (such as those discussed under Item 1A. Risk Factors - "The Company depends on its Oxford, North Carolina facility for production of a substantial portion of its products. Disruptions at this facility and/or at other Company or third-party facilities at which the Company's products are manufactured could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows"), could have a material adverse effect on the Company's ability to ship and deliver products to meet its customers’ reset deadlines.
Each of the risks referred to above could delay or impede the Company's ability to achieve its sales objectives, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company depends on a limited number of customers for a large portion of its net sales, and the loss of one or more of these customers could reduce the Company's net sales and have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
Walmart and its affiliates worldwide accounted for approximately 15% of the Company’s worldwide net sales in both 2019 and 2018. The Company expects that, for future periods, Walmart and a small number of other customers will, in the aggregate, continue to account for a large portion of the Company's net sales. The Company may be affected by changes in the policies and demands of its customers relating to service levels, inventory de-stocking, pricing, marketing, advertising and/or promotional strategies or limitations on access to wall display space. As is customary in the consumer products industry, none of the Company's customers is under any obligation to continue purchasing products from the Company in the future.
The loss of Walmart and/or one or more of the Company's other customers that account for a significant portion of the Company's net sales, or any significant decrease in sales to these customers, including as a result of consolidation among such customers, retail store closures in response to the growth in retail sales through e-commerce channels, inventory management by these customers, changes in pricing, marketing, advertising and/or promotional strategies by such customers or space reconfigurations by the Company's customers or any significant decrease in the Company's display space, could reduce the Company's net sales and/or operating income and therefore could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company may be unable to maintain or increase its sales through the Company's primary retailers, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
A decrease in consumer demand in the U.S. and/or internationally for beauty products, inventory management by the Company's customers, changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers (such as the development and/or continued expansion of private label or their own store-owned brands), a reduction in display space by the Company's customers, store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels and/or a change in consumers’ purchasing habits, such as with respect to retailer preferences and/or sales channels, could result in decreased sales of the Company's products, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
Competition in the beauty industry could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The beauty industry is highly competitive. The Company competes primarily by:
developing quality products with innovative performance features, shades, finishes, components and packaging;
educating consumers, retail customers and salon professionals about the benefits of the Company’s products both on-line and in brick and mortar retail outlets;
anticipating and responding to changing consumer, retail customer and salon professional demands in a timely manner, including as to the timing of new product introductions and line extensions;
offering attractively priced products relative to the product benefits provided;
maintaining favorable brand recognition;
generating competitive margins and inventory turns for the Company’s customers by providing relevant products and executing effective pricing, incentive and promotional programs and marketing and advertising campaigns, as well as social media and influencer marketing activities;
21

Table of Contents

REVLON, INC. AND SUBSIDIARIES
ensuring product availability through effective planning and replenishment collaboration with the Company's customers;
providing strong and effective advertising, promotion, marketing, social media, influencer and merchandising support;
leveraging e-commerce, social media and mobile commerce initiatives and developing an effective omni-channel strategy to optimize the opportunity for consumers to interact with and purchase the Company's products both on-line and in brick and mortar retail outlets;
maintaining an effective sales force and distribution network; and
obtaining and retaining sufficient display space, optimal in-store positioning and effective presentation of the Company’s products on-shelf.
An increase in or change in the current level of competition that the Company faces could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
In addition to competing with expanding private label and store-owned brands, the Company competes against a number of multi-national manufacturers, some of which are larger and have substantially greater resources than the Company, and which may therefore have the ability to spend more aggressively than the Company on new business acquisitions, research and development activities, technological advances to evolve in their e-commerce capabilities and advertising, promotional, social media influencer and/or marketing activities and have more flexibility than the Company to respond to changing business and economic conditions.
Additionally, the Company's major customers periodically assess the allocation of display space among competitors and in the course of doing so could elect to reduce the display space allocated to the Company's products, if, for example, the Company's marketing, promotional, advertising and/or pricing strategies for its new and/or existing products are less effective than planned, fail to effectively reach the targeted consumer base, fail to engender the desired consumption of the Company's products by consumers and/or fail to sustain productive levels of consumption dollar share and/or the rate of purchases by the Company's consumers are not as high as the Company anticipates. Among the factors used by the Company’s major customers in assessing the allocation of display space is a brand’s share of the color cosmetics category. The Company's color cosmetics brands have experienced, over time, year-over-year declines in their share of the color cosmetics category in the U.S. and it is possible that the Company may continue to experience further share declines. Further declines in the Company's share for one or more of its principal brands, including with respect to the Company’s Almay brand, could, among other things, contribute to the additional loss of display space and/or decreased revenues. Any significant loss of display space could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company's Fragrances segment depends on various brand licenses and distribution arrangements for a significant portion of its sales, and the loss of one or more of these licenses or distribution arrangements could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company’s rights to market and sell certain of its prestige fragrance brands are derived from licenses and other distribution arrangements from unaffiliated third parties and such business is dependent upon the continuation and renewal of such licenses and distribution arrangements on terms favorable to the Company. Each license is for a specific term and may have optional renewal terms. In addition, such licenses and distribution arrangements may be subject to the Company satisfying required minimum royalty payments, minimum advertising and promotional expenditures and satisfying minimum sales requirements. In addition, under certain circumstances, lower net sales may shorten the duration of the applicable license agreement. The loss of one or more of these licenses or other significant distribution arrangements, renewal of one or more of these arrangements on less than favorable terms, the failure to renew one or more of these arrangements and/or difficulties in finding replacement brand licenses for terminated or expired licenses could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.
22

Table of Contents

REVLON, INC. AND SUBSIDIARIES
The success of the Company's Fragrances segment depends, in part, on the demand for heritage and designer fragrance products. A decrease in demand for such products, or the loss or infringement of any intellectual property rights, could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The Company's Fragrances segment has license agreements to manufacture, market and distribute a number of heritage and designer fragrance products, including those of (i) Juicy Couture, John Varvatos and AllSaints in prestige fragrances; (ii) Britney Spears, Christina Aguilera, Elizabeth Taylor, Jennifer Aniston and Mariah Carey in celebrity fragrances; and (iii) Ed Hardy, Lucky Brand and Geoffrey Beene in mass fragrances. In 2019, the Company's Fragrances segment derived approximately 60% of its net sales from heritage and designer fragrance brands. The demand for these products is, to some extent, dependent on the appeal to consumers of the particular designer or talent and the designer’s or talent’s reputation. The Company also cannot assure that the owners of the trademarks that it licenses can or will successfully maintain their intellectual property rights. If other parties infringe on the intellectual property rights that the Company licenses, the value of such brands in the marketplace may be diluted. To the extent that the heritage or designer fragrance category or a particular designer or talent ceases to be appealing to consumers or a designer’s or talent’s reputation is adversely affected, sales of the related products and the value of the impacted brands could decrease materially, which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.
The Company's inability to acquire or license additional fragrance brands or secure additional distribution arrangements and arrangements could have an adverse effect on the Company's net sales and a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
The success of the Fragrances segment depends in part upon the continued growth of its portfolio of owned, licensed and distributed brands, including expanding its geographic presence to take advantage of opportunities in developed and emerging regions. Efforts to increase sales of the Company's prestige fragrance portfolio and expand its geographic market presence depend upon a number of factors, including its ability to: